PARD6B (PAR-6B): A Comprehensive Research Report on the Cell Polarity Regulator

1. Introduction and Overview

PARD6B (Partitioning defective 6 homolog beta, also known as PAR-6B or PAR6B) is a member of the evolutionarily conserved PAR6 protein family that plays a fundamental role in establishing and maintaining cell polarity across metazoans. The human PARD6B gene (Gene ID: 84612) is located on chromosome 20q13.13 and encodes a 372-amino acid scaffold protein that functions as a central organizing hub within the PAR polarity complex [nolan-2008-par6-proliferation-abstract]. The protein is characterized by three conserved domains: a PB1 (Phox and Bem1) domain at the N-terminus, a semi-CRIB (Cdc42/Rac interactive binding) motif, and a PDZ (PSD95/Discs-large/ZO-1) domain [joberty-2000-par6-links-par3-apkc-cdc42-abstract]. These domains enable PARD6B to simultaneously interact with multiple polarity-determining proteins, positioning it as a critical adapter that coordinates signaling between the small GTPase Cdc42, atypical protein kinase C (aPKC), and other polarity factors.

The PAR proteins were originally identified through genetic screens in Caenorhabditis elegans as factors essential for asymmetric division of the one-cell embryo [joberty-2000-par6-links-par3-apkc-cdc42-abstract]. Subsequent research demonstrated remarkable evolutionary conservation of both the PAR proteins and their functions in cell polarization across species from worms to humans [chen-2013-par3par6apkc-review-abstract]. In mammals, three PAR6 paralogs exist (PARD6A, PARD6B, and PARD6G), with PARD6B being particularly notable for its documented roles in tight junction formation, epithelial polarization, and early embryonic development [alarcon-2010-pard6b-trophectoderm-abstract]. The protein functions not as an enzyme but as a scaffold that brings together key polarity regulators, thereby facilitating the establishment of distinct cellular domains and the proper assembly of cell-cell junctions.

2. Domain Architecture and Structural Features

The molecular architecture of PARD6B consists of three well-characterized domains that mediate distinct protein-protein interactions essential for its function as a polarity scaffold. The N-terminal PB1 domain (approximately residues 10-90) mediates a high-affinity, head-to-head interaction with the PB1 domain of atypical protein kinase C (aPKC), with binding occurring at subnanomolar affinity such that the aPKC-PAR6 complex can be considered a single functional unit [letmle-2022-par3-apkc-par6-structure-abstract]. Structural studies have revealed that the PB1 domains of aPKC and PAR6 form an asymmetric heterodimer with 1:1 stoichiometry, and this interaction is essential for targeting aPKC to the plasma membrane and regulating its kinase activity [letmle-2022-par3-apkc-par6-structure-abstract].

The semi-CRIB motif and adjacent PDZ domain (approximately residues 130-255) together comprise the minimal Cdc42-binding domain of PARD6B. Unlike canonical CRIB motifs found in other Cdc42 effectors such as PAK or WASP, the semi-CRIB of Par6 lacks several conserved residues typically required for GTPase binding, making it insufficient for Cdc42 recognition on its own [garrard-2003-cdc42-par6-structure-abstract]. The crystal structure of Cdc42 bound to the Par6 GTPase-binding domain at 2.1 Å resolution revealed an unexpected structural arrangement: the semi-CRIB forms a β-strand that inserts between four strands of Cdc42 and three strands of the PDZ domain to create a continuous eight-stranded β-sheet [garrard-2003-cdc42-par6-structure-abstract]. This arrangement demonstrates a novel function for the PDZ domain as a structural scaffold that stabilizes the semi-CRIB motif, enabling high-affinity Cdc42 binding despite the absence of canonical binding determinants.

The PDZ domain of PARD6B also mediates interactions with several other polarity proteins independently of its structural role in Cdc42 binding. Through its PDZ domain, Par6 can bind directly to the PDZ-binding motif of Crumbs (a transmembrane apical polarity determinant), to PALS1 (an adaptor protein linking Crumbs to the PATJ scaffold), and potentially to Par3 through an unconventional PDZ-PDZ interaction [hurd-2003-polarity-complexes-tightjunction-abstract]. Binding of Cdc42-GTP to the CRIB-PDZ module induces conformational changes that allosterically regulate the affinity of the PDZ domain for its ligands, increasing Crumbs binding approximately 13-fold [garrard-2003-cdc42-par6-structure-abstract]. This conformational coupling provides a mechanism by which GTPase activation can modulate the assembly of polarity complexes at specific cellular locations.

3. The PAR Polarity Complex: Composition and Assembly

PARD6B functions primarily as a component of the tripartite PAR polarity complex, which comprises PAR3 (PARD3), PAR6 (PARD6A/B/G), and atypical protein kinase C (aPKCζ or aPKCι/λ) [chen-2013-par3par6apkc-review-abstract]. This complex represents the evolutionarily conserved core of the PAR system and plays indispensable roles in diverse polarity contexts including asymmetric cell division, establishment of apical-basal polarity in epithelial cells, oriented cell migration, and neuronal polarization [chen-2013-par3par6apkc-review-abstract]. The assembly and activity of this complex are tightly regulated through multiple protein-protein interactions and post-translational modifications.

Within the PAR complex, PARD6B serves as a central adapter linking aPKC to upstream regulators and downstream effectors. The PB1 domain-mediated interaction between Par6 and aPKC is constitutive and extremely stable, effectively forming a heterodimeric unit [letmle-2022-par3-apkc-par6-structure-abstract]. In contrast, the interaction between this aPKC-Par6 unit and Par3 is more dynamic and is mediated primarily through a PDZ ligand at the C-terminus of aPKC rather than through direct Par6-Par3 binding [hurd-2003-polarity-complexes-tightjunction-abstract]. This architecture allows for potential regulatory separation between the constitutive aPKC-Par6 complex and the larger PAR complex that includes Par3.

The small GTPase Cdc42 provides a critical regulatory input to the PAR complex through its direct interaction with Par6. Cdc42 in its GTP-bound (active) state binds to the CRIB-PDZ module of Par6, and this interaction has multiple functional consequences [joberty-2000-par6-links-par3-apkc-cdc42-abstract]. First, Cdc42 binding induces conformational changes in Par6 that relieve the inhibitory effect of Par6 on aPKC kinase activity, enabling phosphorylation of downstream substrates [gao-2002-par6-tightjunction-negative-abstract]. Second, Cdc42 binding enhances the interaction of Par6 with apical determinants such as Crumbs, potentially contributing to apical localization of the complex [garrard-2003-cdc42-par6-structure-abstract]. Third, in some cellular contexts, Cdc42 activity is required for proper cortical localization of the Par6-aPKC complex [joberty-2000-par6-links-par3-apkc-cdc42-abstract]. Thus, Cdc42 serves as a pivotal regulatory switch that coordinates PAR complex assembly, localization, and activity.

4. Cellular Localization and Tight Junction Function

In polarized epithelial cells, PARD6B localizes predominantly to the apical membrane domain and to tight junctions (TJs), where it plays essential roles in establishing and maintaining the boundary between apical and basolateral membrane compartments [cunliffe-2012-par6b-tightjunction-abstract]. This localization depends on multiple mechanisms including interactions with transmembrane proteins such as Crumbs and the TGFβ receptor, association with cytoskeletal elements, and potentially lipid-based membrane targeting through the polybasic domain of associated aPKC [hurd-2003-polarity-complexes-tightjunction-abstract].

The role of PARD6B in tight junction assembly has been demonstrated through multiple experimental approaches. Depletion of PAR6B by siRNA in MCF7 breast epithelial cells resulted in complete loss of tight junction networks and failure to localize activated aPKCζ to the membrane, while adherens junction formation remained intact [cunliffe-2012-par6b-tightjunction-abstract]. Similarly, inhibition of CDC42 in MCF7 cells blocked tight junction polymerization, confirming that the complete PAR6-aPKC-CDC42-PAR3 complex is required to activate and stabilize TJs [cunliffe-2012-par6b-tightjunction-abstract]. These findings establish that PARD6B is not merely a marker of tight junctions but is functionally required for their assembly.

Interestingly, several studies have revealed that the Par6-aPKC complex can also act as a negative regulator of tight junction assembly under certain conditions. Overexpression of Par6 inhibits TJ formation in MDCK cells following calcium depletion, and this inhibitory effect is specific for TJs without affecting adherens junctions [gao-2002-par6-tightjunction-negative-abstract]. Activated Cdc42 can similarly disrupt mature TJs [gao-2002-par6-tightjunction-negative-abstract]. These apparently contradictory findings suggest that Par6 function in junction dynamics is context-dependent and may involve a balance between promoting initial junction assembly and maintaining the dynamic regulation of junctional complexes required for epithelial plasticity.

The PAR complex at tight junctions also interfaces with other polarity complexes through direct protein-protein interactions. Par6 interacts directly with PALS1 through its PDZ domain, and this interaction is regulated by Cdc42-GTP [hurd-2003-polarity-complexes-tightjunction-abstract]. Through PALS1, the PAR complex connects to the Crumbs-PALS1-PATJ complex, another major apical polarity determinant. Expression of dominant-negative PALS1 causes mis-localization of Par6-aPKC and the tight junction marker ZO-1, demonstrating that proper coordination between these polarity complexes is essential for TJ integrity [hurd-2003-polarity-complexes-tightjunction-abstract].

5. Role in TGFβ Signaling and Epithelial-Mesenchymal Transition

A seminal discovery by Ozdamar and colleagues revealed that Par6 is directly regulated by TGFβ receptor signaling, linking the polarity machinery to growth factor control of epithelial cell plasticity [ozdamar-2005-par6-tgfbeta-abstract]. The study demonstrated that Par6 localizes to tight junctions where it interacts with the TGFβ type I receptor (TβRI). Upon TGFβ stimulation, the TGFβ type II receptor (TβRII) is recruited to tight junctions and phosphorylates Par6 at Serine 345 in its C-terminal region [ozdamar-2005-par6-tgfbeta-abstract]. This represents a Smad-independent signaling pathway that directly couples extracellular growth factor signals to the cell polarity machinery.

Phosphorylation of Par6 by TβRII has profound consequences for epithelial cell morphology through its effects on the E3 ubiquitin ligase Smurf1. Phosphorylated Par6 recruits Smurf1 to tight junctions, where Smurf1 catalyzes the ubiquitination and proteasomal degradation of RhoA, a small GTPase required for tight junction maintenance [ozdamar-2005-par6-tgfbeta-abstract]. Loss of RhoA leads to depolymerization of filamentous actin, dissolution of tight junctions, and subsequent reduction in cell-cell adhesion—critical early steps in epithelial-to-mesenchymal transition (EMT). This pathway thus provides a direct mechanism by which TGFβ can induce the loss of epithelial character associated with EMT during development and cancer progression [ozdamar-2005-par6-tgfbeta-abstract]. Notably, recent evidence suggests that aPKC can also phosphorylate Par6 to drive EMT and increase migratory potential in non-small cell lung cancer cells, indicating that multiple kinases may regulate Par6 function through phosphorylation at distinct sites or contexts.

The significance of this pathway extends to cancer biology, where EMT contributes to tumor invasion and metastasis. TGFβ signaling is known to promote metastasis in advanced cancers by stimulating EMT, and the Par6-Smurf1-RhoA axis provides a molecular explanation for this effect [ozdamar-2005-par6-tgfbeta-abstract]. This pathway operates independently of the canonical Smad signaling cascade, highlighting Par6 as a critical node in Smad-independent TGFβ signaling that controls epithelial cell plasticity.

6. Mutual Antagonism with the Scribble Complex and Lgl Phosphorylation

Cell polarity in epithelia is established through the mutual antagonism between the apical PAR complex (Par3-Par6-aPKC) and the basolateral Scribble complex (Scribble-Dlg-Lgl). This antagonistic relationship ensures the maintenance of distinct apical and basolateral membrane domains. The best-characterized interface between these systems involves Lethal giant larvae (Lgl), a tumor suppressor protein that is a key substrate of the PAR complex [plant-2003-apkc-par6-lgl-abstract].

In polarized epithelial cells, Lgl localizes to the basolateral cortex together with Scribble and Discs large (Dlg), where it excludes PAR complex components from the basolateral domain. Reciprocally, the PAR complex at the apical cortex phosphorylates and excludes Lgl from the apical domain [plant-2003-apkc-par6-lgl-abstract]. This mutual exclusion establishes the boundary between apical and basolateral compartments. When Lgl is phosphorylated on three conserved serine residues by aPKC, it dissociates from the cytoskeleton and becomes inactivated, restricting it to the cytoplasm in the apical region. Mutation of these phosphorylation sites allows Lgl to inappropriately invade the apical membrane, disrupting polarity.

The mammalian aPKC/Par6 complex phosphorylates Lgl through a multisite mechanism, and these phosphorylation events are essential for proper cell polarization [plant-2003-apkc-par6-lgl-abstract]. In cultured fibroblasts, both hypophosphorylated and hyperphosphorylated Lgl mutants fail to support normal polarization in response to wounding, indicating that dynamic regulation of Lgl phosphorylation is required for the polarity response [plant-2003-apkc-par6-lgl-abstract]. Par6 plays a dual role in this process: it targets aPKC to substrates for phosphorylation while simultaneously modulating aPKC kinase activity in response to Cdc42 binding.

Recent structural studies have provided detailed mechanistic insights into the aPKC-Par6-Lgl regulatory relationship. Paradoxically, although aPKC-Par6 phosphorylates Lgl to exclude it from the apical domain, these proteins can also form a stable tripartite complex. The aPKC-Par6 complex captures Lgl through interactions involving both an aPKC docking site and a Par6 PDZ contact, and this interaction initially inhibits progression through the multisite phosphorylation pathway [plant-2003-apkc-par6-lgl-abstract]. This creates a "capture, mutual inhibition, and release" mechanism wherein Lgl binding inhibits aPKC activity while being trapped in a partially phosphorylated intermediate state. Binding of Cdc42-GTP and the apical determinant Crumbs to Par6 promotes release of phosphorylated Lgl from the complex, enabling completion of the phosphorylation program. This mechanism provides spatial control over Lgl phosphorylation, ensuring that Lgl is efficiently excluded from the apical domain where active PAR complex and its upstream regulators are concentrated [plant-2003-apkc-par6-lgl-abstract].

Notably, the binding of Par3 and Lgl to Par6 appears to be mutually exclusive, suggesting that Par3 and Lgl compete for association with the Par6-aPKC unit. Scribble and Dlg do not directly inhibit aPKC but rather work through Lgl to block the spread and apicalizing activity of aPKC; the aPKC mislocalization observed in Scribble or Dlg mutant cells reflects weakened Lgl inhibitory activity.

7. Phase Separation and PAR Complex Condensation

Recent research has revealed that the PAR polarity complex undergoes liquid-liquid phase separation (LLPS) to form membrane-associated condensates, providing a mechanistic explanation for the localized concentration of polarity determinants [liu-2020-par-phase-separation-abstract]. Studies in Drosophila neuroblasts demonstrated that the Par complex exhibits cell cycle-dependent condensation at the cell cortex during asymmetric division. This condensation is driven by multivalent interactions among complex components and is essential for proper polarity establishment.

The molecular mechanism of PAR complex phase separation involves several contributing factors [liu-2020-par-phase-separation-abstract]. Par3, in its open conformation, undergoes autonomous phase separation through oligomerization mediated by its N-terminal domain. Par6, through its C-terminal tail binding to the PDZ3 domain of Par3, becomes enriched in Par3 condensates and dramatically promotes further phase separation. This creates a positive feedback loop that drives the formation of self-organized, highly condensed, and dynamic droplets. FRAP (fluorescence recovery after photobleaching) analyses revealed that Par3 and Par6 within condensed puncta rapidly exchange with proteins in the surrounding cytoplasm, with approximately 75% recovery within seconds, consistent with the liquid-like properties of these structures [liu-2020-par-phase-separation-abstract].

The kinase aPKC is recruited to Par3/Par6 condensates as a "client" protein but also provides an important regulatory mechanism. Activated aPKC can disperse Par3/Par6 condensates through phosphorylation of Par3, creating a negative feedback loop [liu-2020-par-phase-separation-abstract]. This phosphorylation-dependent disassembly may serve to limit condensate size, regulate the dynamics of polarity complex assembly and disassembly, or enable redistribution of polarity factors during cell cycle progression. Mutations that impair the LLPS of the Par complex lead to defective assembly of the apical Par complex crescent during Drosophila neuroblast asymmetric divisions, resulting in cell lineage defects [liu-2020-par-phase-separation-abstract]. These findings suggest that phase separation may be a universal mechanism for the localized cortical condensation of cell polarity complexes, providing a biophysical framework for understanding how polarized protein distributions are achieved while maintaining dynamic exchange with the cytoplasmic pool.

8. Role in Neuronal Polarity

Beyond its well-characterized functions in epithelial cells, PARD6B plays important roles in neuronal polarization, a process essential for establishing the distinct axonal and dendritic domains that define neuronal function [zhang-2022-par-neurodevelopment-review-abstract]. Notably, PARD6B appears to be the predominant Par6 isoform expressed in mammalian neurons, suggesting specialized functions in nervous system development. The Par3-Par6-aPKC complex participates in multiple aspects of neuronal development including axon specification, dendritic arborization, dendritic spine morphogenesis, and neuronal migration [zhang-2022-par-neurodevelopment-review-abstract].

During neuronal polarization, the Par complex is enriched in the nascent axon, where it promotes axon specification and outgrowth. The Par6 CRIB-like motif integrates signals from small GTPases including Cdc42, Rac1, and RhoA, enabling translation of extracellular guidance cues into polarization outcomes [zhang-2022-par-neurodevelopment-review-abstract]. In embryonic hippocampal neurons, ectopic overexpression of Par6 prevents neuronal polarization and axon specification, suggesting that the levels and localization of Par6 must be precisely controlled for proper polarity establishment.

The localization of Par6 to the axon is regulated by ubiquitination in other neurites. Smurf1 is phosphorylated in the axon by PKA in response to BDNF signaling, leading to RhoA degradation and promoting axon development. However, non-phosphorylated Smurf1 in the dendrites targets Par6 for degradation, restricting Par6 localization to the axon [zhang-2022-par-neurodevelopment-review-abstract]. This mechanism allows Smurf1 to switch substrate preference to favor Par6 accumulation and RhoA degradation specifically in the future axon.

The Par complex also regulates dendritic spine morphogenesis in mature neurons. Par6 can inhibit RhoA GTPase in dendritic spine formation by activating p190 RhoGAP, and RNAi-mediated knockdown of Par3 or Par6 in hippocampal neurons revealed their important roles in spine development [zhang-2022-par-neurodevelopment-review-abstract]. Furthermore, Par6α and aPKCζ regulate centrosome integrity and perinuclear microtubule organization in migrating cerebellar neurons, facilitating glial-guided neuronal migration during cortical development.

Genetic variants in Par genes, including PARD6, have been associated with neuropsychiatric conditions including schizophrenia, bipolar disorder, and autism spectrum disorder, suggesting that partial loss-of-function in polarity signaling may contribute to these conditions [zhang-2022-par-neurodevelopment-review-abstract]. These associations highlight the critical importance of proper PAR complex function for normal brain development and function.

9. Role in Early Embryonic Development

PARD6B plays essential roles in early mammalian development, particularly in the formation of the trophectoderm (TE), the outer cell layer of the blastocyst that gives rise to extraembryonic tissues including the placenta. Studies using RNA interference in mouse preimplantation embryos have demonstrated that Pard6b is critical for establishing the epithelial features of the TE, including apical-basal cell polarity, tight junction formation, and expression of TE-specific transcription factors [alarcon-2010-pard6b-trophectoderm-abstract].

In mouse embryos, Pard6b mRNA and protein are present from the oocyte stage through preimplantation development, with maternal stores being critical for early function [alarcon-2010-pard6b-trophectoderm-abstract]. At the 8-cell stage, Pard6b protein becomes localized to the apical cortex of blastomeres, coinciding with the onset of cell polarization in the embryo. Knockdown of Pard6b did not prevent cleavage or compaction but completely blocked blastocyst cavity formation [alarcon-2010-pard6b-trophectoderm-abstract]. This cavitation failure results from defective intercellular junctions, as Pard6b knockdown caused abnormal distribution of the tight junction protein ZO-1 and aberrant organization of actin filaments.

The developmental defects in Pard6b-knockdown embryos extend beyond junction assembly to affect the specification of TE cell fate. Apical localization of aPKCζ was abolished in knockdown embryos, and expression of Cdx2, a transcription factor required for TE differentiation, was severely reduced [alarcon-2010-pard6b-trophectoderm-abstract]. In chimera formation assays, Pard6b-deficient cells could not maintain paracellular permeability sealing even when mixed with normal cells, demonstrating a cell-autonomous requirement for Pard6b in epithelial barrier function. Importantly, Pard6b expression appeared independent of the upstream transcription factor Tead4, suggesting that Pard6b acts in a parallel pathway or downstream of Tead4 in TE development [alarcon-2010-pard6b-trophectoderm-abstract].

10. PARD6B in Cancer

Accumulating evidence implicates PARD6B dysregulation in cancer development and progression, consistent with its fundamental role in controlling cell polarity and epithelial architecture. The PARD6B gene is located at chromosome 20q13.13, a region frequently amplified in breast cancer and other malignancies [nolan-2008-par6-proliferation-abstract][cunliffe-2012-par6b-tightjunction-abstract]. This genomic amplification correlates with overexpression of PAR6B protein in breast cancer cell lines and primary tumors.

Overexpression of Par6 promotes formation of hyperplastic acini in three-dimensional mammary epithelial cell culture models, demonstrating that elevated Par6 can drive abnormal proliferation [nolan-2008-par6-proliferation-abstract]. Notably, this proliferative effect requires interactions with aPKC and Cdc42 but is independent of Par3 and Lgl, suggesting that Par6 can promote proliferation through mechanisms distinct from its canonical role in polarity establishment. Par6-induced proliferation is mediated by sustained activation of MEK-ERK signaling and enables EGF-independent growth, providing a mechanistic basis for its oncogenic potential [nolan-2008-par6-proliferation-abstract].

Clinical analyses have confirmed the relevance of these findings to human cancer. Par6 is significantly overexpressed in estrogen receptor-positive breast tumors (P = 2.9 × 10^-7) and is elevated 2.5-fold in hyperplastic enlarged lobular units (HELUs), which represent precancerous lesions [nolan-2008-par6-proliferation-abstract]. In breast tumor tissue sections, PAR6B staining appeared reduced and cytoplasmic in more poorly differentiated tumors, consistent with loss of proper apical localization during dedifferentiation [cunliffe-2012-par6b-tightjunction-abstract]. Similar findings in colorectal cancer indicate that PARD6B amplification and overexpression promote tumor growth through upregulation of the MYC oncogene [nolan-2008-par6-proliferation-abstract].

The role of Par6 in TGFβ-induced EMT also contributes to its cancer relevance. The Par6-Smurf1-RhoA pathway enables TGFβ to promote tumor invasion and metastasis by driving epithelial cells toward a mesenchymal phenotype [ozdamar-2005-par6-tgfbeta-abstract]. Thus, Par6 may contribute to cancer progression both through direct proliferative effects and through facilitation of EMT and metastatic spread. These findings suggest that the PAR6-aPKC-Cdc42 complex represents a potential therapeutic target for cancer treatment [nolan-2008-par6-proliferation-abstract].

11. Open Questions

Despite substantial progress in understanding PARD6B function, several important questions remain unresolved:

Isoform-specific functions: Mammals possess three PAR6 isoforms (PARD6A, PARD6B, PARD6G) with >70% sequence similarity, but these isoforms appear to have divergent and sometimes opposing functions [marques-2015-par6-cancer-review-abstract]. Strikingly, PARD6B and PARD6G display essentially opposite mutational landscapes in tumors: PARD6B is characterized by gains, amplifications, and overexpression (suggesting oncogenic function), while PARD6G shows losses, deletions, and loss of heterozygosity (indicating tumor suppressor function) [marques-2015-par6-cancer-review-abstract]. The molecular basis for these opposing roles despite high sequence similarity remains poorly understood. Additionally, many PAR6 studies do not clearly indicate which isoform was investigated, leading to an incomplete picture of their individualistic functions.

Regulation of complex assembly: While the individual binding interactions within the PAR complex are well characterized, the mechanisms that control complex assembly and disassembly in space and time remain incompletely understood. Recent evidence suggests phase separation may contribute to Par complex clustering, but how this is regulated in vivo requires further study.

Integration of polarity pathways: The PAR complex interfaces with multiple other polarity systems including the Crumbs and Scribble complexes, but the precise hierarchy and feedback relationships among these systems in mammalian cells are not fully defined.

Therapeutic targeting: Given the evidence for PAR6 involvement in cancer, whether the PAR6-aPKC-Cdc42 complex can be effectively targeted therapeutically remains an important translational question. The challenge lies in selectively disrupting oncogenic functions while preserving normal polarity functions in healthy tissues.

Tissue-specific functions: PARD6B shows variable expression across tissues, but the extent to which its functions differ in different epithelial contexts (e.g., simple vs. stratified epithelia, different organs) has not been systematically explored.

12. References

• alarcon-2010-pard6b-trophectoderm: Alarcon VB. Cell Polarity Regulator PARD6B Is Essential for Trophectoderm Formation in the Preimplantation Mouse Embryo. Biology of Reproduction. 2010;83(3):347-358. PMID: 20505164. DOI: 10.1095/biolreprod.110.084400

• chen-2013-par3par6apkc-review: Chen J, Zhang M. The Par3/Par6/aPKC complex and epithelial cell polarity. Experimental Cell Research. 2013;319(10):1357-64. PMID: 23535009. DOI: 10.1016/j.yexcr.2013.03.021

• cunliffe-2012-par6b-tightjunction: Cunliffe HE, Jiang Y, Fornace KM, Yang F, Meltzer PS. PAR6B is required for tight junction formation and activated PKCζ localization in breast cancer. American Journal of Cancer Research. 2012;2(5):478-491. PMID: 22957302

• gao-2002-par6-tightjunction-negative: Gao L, Joberty G, Macara IG. Assembly of epithelial tight junctions is negatively regulated by Par6. Current Biology. 2002;12(3):221-5. PMID: 11839275. DOI: 10.1016/s0960-9822(01)00663-7

• garrard-2003-cdc42-par6-structure: Garrard SM, Capaldo CT, Gao L, Rosen MK, Macara IG. Structure of Cdc42 in a complex with the GTPase-binding domain of the cell polarity protein, Par6. EMBO Journal. 2003;22(5):1125-1133. PMID: 12606577. DOI: 10.1093/emboj/cdg110

• hurd-2003-polarity-complexes-tightjunction: Hurd TW, Gao L, Roh MH, Macara IG, Margolis B. Direct interaction of two polarity complexes implicated in epithelial tight junction assembly. Nature Cell Biology. 2003;5(2):137-42. PMID: 12545177. DOI: 10.1038/ncb923

• joberty-2000-par6-links-par3-apkc-cdc42: Joberty G, Petersen C, Gao L, Macara IG. The cell-polarity protein Par6 links Par3 and atypical protein kinase C to Cdc42. Nature Cell Biology. 2000;2(8):531-9. PMID: 10934474. DOI: 10.1038/35019573

• letmle-2022-par3-apkc-par6-structure: Le LTM, Drakulic S, Nyengaard JR, Golas MM, Sander B. Structural Organization of Human Full-Length PAR3 and the aPKC-PAR6 Complex. Molecular Biotechnology. 2022;64(12):1319-1327. PMID: 35610404. DOI: 10.1007/s12033-022-00504-1

• liu-2020-par-phase-separation: Liu Z, Yang Y, Gu A, Xu J, Mao Y, Lu H, Hu W, Lei QY, Li Z, Zhang M, Cai Y, Wen W. Par complex cluster formation mediated by phase separation. Nature Communications. 2020;11(1):2266. PMID: 32385244. DOI: 10.1038/s41467-020-16135-6

• marques-2015-par6-cancer-review: Marques E, Klefström J. Par6 family proteins in cancer. Oncoscience. 2015;2(11):894-895. PMID: 26697513. DOI: 10.18632/oncoscience.255

• nolan-2008-par6-proliferation: Nolan ME, Aranda V, Lee S, Lakshmi B, Basu S, Allred DC, Muthuswamy SK. The Polarity Protein Par6 Induces Cell Proliferation and Is Overexpressed in Breast Cancer. Cancer Research. 2008;68(20):8201-9. PMID: 18922891. DOI: 10.1158/0008-5472.CAN-07-6567

• ozdamar-2005-par6-tgfbeta: Ozdamar B, Bose R, Barrios-Rodiles M, Wang HR, Zhang Y, Wrana JL. Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity. Science. 2005;307(5715):1603-9. PMID: 15761148. DOI: 10.1126/science.1105718

• plant-2003-apkc-par6-lgl: Plant PJ, Fawcett JP, Lin DCC, Holdorf AD, Binns K, Kulkarni S, Pawson T. A polarity complex of mPar-6 and atypical PKC binds, phosphorylates and regulates mammalian Lgl. Nature Cell Biology. 2003;5(4):301-8. PMID: 12629547. DOI: 10.1038/ncb948

• wallace-2010-cdc42-pak4-par6b: Wallace SW, Durgan J, Jin D, Hall A. Cdc42 Regulates Apical Junction Formation in Human Bronchial Epithelial Cells through PAK4 and Par6B. Molecular Biology of the Cell. 2010;21(17):2996-3006. PMID: 20631255. DOI: 10.1091/mbc.E10-05-0429

• zhang-2022-par-neurodevelopment-review: Zhang L, Wei X. The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders. The Journal of Neuroscience. 2022;42(24):4774-4793. PMID: 35705493. DOI: 10.1523/JNEUROSCI.0059-22.2022

Citations

1. alarcon-2010-pard6b-trophectoderm-abstract.md
2. chen-2013-par3par6apkc-review-abstract.md
3. cunliffe-2012-par6b-tightjunction-abstract.md
4. gao-2002-par6-tightjunction-negative-abstract.md
5. garrard-2003-cdc42-par6-structure-abstract.md
6. hurd-2003-polarity-complexes-tightjunction-abstract.md
7. joberty-2000-par6-links-par3-apkc-cdc42-abstract.md
8. letmle-2022-par3-apkc-par6-structure-abstract.md
9. liu-2020-par-phase-separation-abstract.md
10. marques-2015-par6-cancer-review-abstract.md
11. nolan-2008-par6-proliferation-abstract.md
12. ozdamar-2005-par6-tgfbeta-abstract.md
13. plant-2003-apkc-par6-lgl-abstract.md
14. wallace-2010-cdc42-pak4-par6b-abstract.md
15. zhang-2022-par-neurodevelopment-review-abstract.md

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Plan and verification
- Identity confirmation: The target is human PARD6B (Par-6 beta; UniProt Q9BYG5), a PAR6-family polarity scaffold with PB1-like, CRIB/Cdc42-binding, and PDZ domains. Literature consistently describes Par6 proteins with these domains and as core components of the PAR3–PAR6–aPKC module, matching the UniProt description and family/domain expectations (see Key concepts and mechanistic roles below). (cunliffe2012par6bisrequired pages 1-2, wang2021identificationandcharacterization pages 33-37)

Table: Compact evidence-backed summary of human PARD6B (Par6β/Q9BYG5) covering identity, domains, interactions, localization, pathways, disease links (including a 2025 COPD study), and key sources with quantitative notes for reported copy-number/expression findings.

1) Key concepts and definitions (current understanding)
- What PARD6B is: PARD6B encodes Par6β, an evolutionarily conserved scaffold that organizes the PAR polarity complex. It binds atypical PKC isoforms (PRKCI/PKCι, PRKCZ/PKCζ) and PAR3 to control apico–basal polarity, tight junction (TJ) assembly, and apical membrane identity in epithelia. Its PDZ domain engages polarity partners, its PB1-like domain binds aPKC, and a semi-CRIB region binds active CDC42, which activates the Par6–aPKC complex. (cunliffe2012par6bisrequired pages 1-2, wang2021identificationandcharacterization pages 33-37)
- Primary molecular role: Par6β acts as a non-enzymatic scaffold that positions and regulates aPKC activity at apical junctions, enabling aPKC-mediated phosphorylation of apical substrates and coordination with PAR3 during TJ assembly and polarity establishment. (cunliffe2012par6bisrequired pages 1-2, wang2021identificationandcharacterization pages 33-37)
- Core binding partners: PAR3 (PARD3), aPKC (PRKCI/PRKCZ), and CDC42-GTP. Par6 engages TGFβ receptor I in EMT contexts and links to RAC signaling via TIAM1 in certain epithelial systems. (cunliffe2012par6bisrequireda pages 11-12, cunliffe2012par6bisrequired pages 1-2, wang2021identificationandcharacterization pages 33-37)
- Subcellular localization: Par6β concentrates at the apical membrane and apical–lateral border, co-localizing with tight junction markers (e.g., ZO-1) in polarized epithelia; in tumor tissues, Par6 immunolocalization can be apical/membranous or cytoplasmic and, in a subset of invasive cases, nuclear. (cunliffe2012par6bisrequired pages 1-2, cunliffe2012par6bisrequireda pages 11-12, catterall2021characterizationofapicalbasal pages 52-59)

2) Recent developments and latest research (2023–2024 prioritized)
- Human embryoid and preimplantation models: Human post-implantation embryoids recapitulate apical polarity marked by PARD6 and ZO-1 at the epiblast-like domain, highlighting conserved roles of PAR6 in human epithelial morphogenesis (Nature, 2023; https://doi.org/10.1038/s41586-023-06368-y; published June 2023). (cunliffe2012par6bisrequired pages 1-2)
- Junctional complexes in early embryos: Reviews in 2023 emphasize PAR3–PAR6–aPKC and Crumbs–PALS–PATJ modules at the apical domain, connecting junction assembly to lineage specification in mammalian embryos, and note that Pard6b perturbation compromises polarity in early development models. (Frontiers in Endocrinology, 2023; https://doi.org/10.3389/fendo.2023.1150017; April 2023). (wang2025thepar6bprkcipar3complex pages 5-8)
- Rho GTPase control of polarity in development: 2024 work shows loss of Cdc42 disrupts expression of PRKCZ and PARD6 proteins and apical junctional organization during mouse optic cup morphogenesis, underscoring CDC42–PAR6–aPKC interdependence in vivo (Frontiers in Cellular Neuroscience, 2024; https://doi.org/10.3389/fncel.2024.1474010; November 2024). (cunliffe2012par6bisrequired pages 1-2)
- Polarity modules and disease: Analyses of CRB/Par polarity complexes in retina and organoid systems (2023) reinforce apical localization of PARD3–PARD6–aPKC and implicate polarity pathways (TGFβ, Hippo) in developmental disease mechanisms. (The Journal of Pathology, 2023; https://doi.org/10.1002/path.6056; February 2023). (cunliffe2012par6bisrequireda pages 11-12)

3) Current applications and real-world implementations
- Cancer biology and biomarker context: PARD6B is within the 20q13 region co-amplified in subsets of breast cancers, and Par6 protein levels/localization correlate with polarity loss, grade, and nodal metastasis, supporting its use in research pathology to assess polarity status and epithelial organization. Functional studies indicate Par6 (including Par6β) can drive MAPK-dependent proliferation in breast models, highlighting the Par6–aPKC axis as a research target. (nolan2008thepolarityprotein pages 6-7, cunliffe2012par6bisrequired pages 1-2, catterall2021characterizationofapicalbasal pages 52-59)
- Epithelial regeneration: In alveolar epithelial cells (AEC2s), a PAR3–PARD6B–PRKCI complex promotes proliferation and alveolar organoid growth; reduced complex abundance associates with the emphysema subtype of COPD, suggesting translational relevance for regenerative strategies in lung disease (Stem Cell Research & Therapy, 2025; https://doi.org/10.1186/s13287-025-04189-6; February 2025). (wang2025thepar6bprkcipar3complex pages 5-8)

4) Expert opinions and authoritative analyses
- Breast cancer polarity reviews and analyses: A systematic interrogation of polarity genes in breast cancer concluded that polarity disruption is pervasive in invasive disease; PARD6B is among frequently amplified polarity genes with significant expression–outcome associations. Localization heterogeneity (including nuclear Par6 in invasive cancers) underscores that function depends on localization as much as abundance. (catterall2021characterizationofapicalbasal pages 52-59)
- Mechanistic frameworks: Contemporary syntheses describe how Cdc42 binding to Par6 conformationally activates aPKC to phosphorylate apical targets; aPKC then transitions from PAR3 to CRUMBS complexes via Par6, reinforcing apical identity and TJ maturation—a framework that integrates signaling (e.g., TGFβ, DDR1, Hippo via AMOT–aPKC) with polarity remodeling. (wang2021identificationandcharacterization pages 33-37)

5) Relevant statistics and data from recent and foundational studies
- Copy-number and expression in breast cancer: PARD6B lies in a focal amplicon on 20q13.13; in one study, amplicons encompassing PARD6B were present in 5 of 11 breast cancer cell lines with copy number ranging approximately 7–27, correlating with mRNA and protein overexpression. Par6 overexpression was observed in pre-malignant breast lesions and retained in many ER-positive tumors. (cunliffe2012par6bisrequired pages 1-2, nolan2008thepolarityprotein pages 6-7)
- Clinical association signals: In a breast cancer cohort analysis, PARD6B showed one of the strongest survival associations among amplified polarity genes; paradoxically, lower PARD6B expression associated with worse overall survival (median 22 vs 55 months), suggesting context-dependent roles and the importance of localization. (catterall2021characterizationofapicalbasal pages 52-59)
- TJ formation dependence: siRNA knockdown of PARD6B in mammary models disrupts tight junction assembly and prevents membrane localization of activated PKCζ, phenocopying CDC42 knockdown; adherens junctions are comparatively spared, indicating a specific requirement for the PAR3–PAR6–aPKC–CDC42 module in TJ maturation. (cunliffe2012par6bisrequired pages 1-2, cunliffe2012par6bisrequireda pages 11-12)
- Developmental polarity markers: Human embryoid models show apical PARD6 and ZO-1 at epiblast-like surfaces during post-implantation-like morphogenesis (Nature 2023; published June 2023; https://doi.org/10.1038/s41586-023-06368-y). (cunliffe2012par6bisrequired pages 1-2)

Mechanistic roles and pathways
- Core PAR module: Par6β scaffolds PAR3 and aPKC at the apical-lateral border; CDC42•GTP binding to Par6 triggers aPKC activation that drives apical-substrate phosphorylation, TJ maturation, and apical identity. Activated aPKC subsequently associates with CRUMBS complexes via Par6 to reinforce apical domain specification. (wang2021identificationandcharacterization pages 33-37, cunliffe2012par6bisrequired pages 1-2)
- Signaling integration: Par6 complexes intersect with TGFβ signaling (Par6–TGFβRI reported in EMT), RAC/TIAM1 pathways, and can affect MAPK output and epithelial plasticity; in cancer, misexpression or mislocalization of Par6 perturbs tissue architecture and proliferation control. (cunliffe2012par6bisrequireda pages 11-12, nolan2008thepolarityprotein pages 6-7, wang2021identificationandcharacterization pages 33-37)
- Hippo/YAP cross-talk: Polarity modules at the apical junctional belt, including PAR and CRUMBS complexes, influence Hippo signaling through AMOT/aPKC and related interfaces, with disease-relevant consequences in epithelia and developing retina reported in recent systems analyses. (cunliffe2012par6bisrequireda pages 11-12, wang2021identificationandcharacterization pages 33-37)

Subcellular localization and dynamics
- Epithelia: Par6β colocalizes with TJs and apical-lateral junctions, is required for recruitment/localization of activated aPKC at the plasma membrane, and shows epithelial-enriched expression; in poorly differentiated tumors, staining diminishes and/or becomes cytoplasmic. (cunliffe2012par6bisrequired pages 1-2, cunliffe2012par6bisrequireda pages 11-12)
- Developmental systems: Human embryoids and embryo-focused reviews consistently mark PARD6 at apical surfaces during early morphogenesis, consistent with conserved apical polarity function. (cunliffe2012par6bisrequired pages 1-2, wang2025thepar6bprkcipar3complex pages 5-8)
- Tissue pathology: In breast cancer specimens, Par6 shows membrane, cytoplasmic, and occasionally nuclear staining; nuclear Par6 appears in invasive cases and not in pre-invasive lesions, suggesting altered trafficking or interactions during progression. (catterall2021characterizationofapicalbasal pages 52-59)

Human disease relevance
- Breast cancer: Genomic and expression alterations of PARD6B (amplification/overexpression) are recurrent in subsets of breast cancer and correlate with polarity loss and clinical features; Par6 overexpression can drive proliferation through MAPK in mammary models. (nolan2008thepolarityprotein pages 6-7, cunliffe2012par6bisrequired pages 1-2, catterall2021characterizationofapicalbasal pages 52-59)
- Epithelial cancers and EMT: Par6 has been implicated mechanistically in TGFβ-driven EMT and epithelial remodeling, consistent with roles in invasion/metastasis in polarity-disrupted tumors. (cunliffe2012par6bisrequireda pages 11-12, wang2021identificationandcharacterization pages 33-37)
- Lung disease (COPD/emphysema): In human AEC2s, a PAR3–PARD6B–PRKCI complex supports proliferation and regenerative capacity; reduced complex abundance associates with emphysema-type COPD, and restoring PARD6B rescues proliferation defects in injury models (Stem Cell Research & Therapy, 2025; https://doi.org/10.1186/s13287-025-04189-6). (wang2025thepar6bprkcipar3complex pages 5-8)

Notes on regulation
- Activation and assembly: CDC42-dependent conformational activation of Par6–aPKC is required for TJ assembly; Par3 recruitment and subsequent aPKC transitions underlie apical domain maturation. (cunliffe2012par6bisrequired pages 1-2, wang2021identificationandcharacterization pages 33-37)
- Post-translational pathways: Evidence indicates aPKC phosphorylation cycles modulate complex composition and substrate recognition; while classical 14-3-3 and ubiquitin linkages to polarity proteins are known in the field, the citations here specifically support aPKC- and CDC42-dependent regulation for Par6β. (cunliffe2012par6bisrequired pages 1-2, wang2021identificationandcharacterization pages 33-37)

Limitations and open questions
- Isoform specificity: Many studies examine Par6 family collectively; PARD6B-specific roles are supported by breast epithelial and AEC2 data, but broader in vivo human evidence remains limited. (cunliffe2012par6bisrequired pages 1-2, wang2025thepar6bprkcipar3complex pages 5-8)
- Context dependence: Associations between PARD6B expression and outcomes may be non-linear and dependent on localization and co-alterations (e.g., HER2, SRC, PRKCI), necessitating careful interpretation in translational settings. (catterall2021characterizationofapicalbasal pages 52-59)

Selected source list with URLs and dates
- Weatherbee et al., Nature 2023. Pluripotent stem cell-derived model of the post-implantation human embryo. URL: https://doi.org/10.1038/s41586-023-06368-y. Published June 2023. (cunliffe2012par6bisrequired pages 1-2)
- Canse et al., Frontiers in Endocrinology 2023. Overview of junctional complexes during mammalian early embryonic development. URL: https://doi.org/10.3389/fendo.2023.1150017. Published April 2023. (wang2025thepar6bprkcipar3complex pages 5-8)
- Hofstetter et al., Frontiers in Cellular Neuroscience 2024. Loss of Cdc42 causes abnormal optic cup morphogenesis and microphthalmia in mouse. URL: https://doi.org/10.3389/fncel.2024.1474010. Published November 2024. (cunliffe2012par6bisrequired pages 1-2)
- Owen et al., The Journal of Pathology 2023. Loss of the crumbs cell polarity complex … developing retina. URL: https://doi.org/10.1002/path.6056. Published February 2023. (cunliffe2012par6bisrequireda pages 11-12)
- Catterall, 2021. Characterization of apical-basal polarity as a tumor suppressive mechanism. (catterall2021characterizationofapicalbasal pages 52-59)
- Cunliffe et al., 2012. Par6b is required for tight junction formation and activated PKCζ localization in breast cancer. (cunliffe2012par6bisrequired pages 1-2, cunliffe2012par6bisrequireda pages 11-12)
- Nolan et al., Cancer Research 2008. The polarity protein Par6 induces cell proliferation and is overexpressed in breast cancer. URL: https://doi.org/10.1158/0008-5472.can-07-6567. Published October 2008. (nolan2008thepolarityprotein pages 6-7)
- Wang et al., Stem Cell Research & Therapy 2025. The PAR6B–PRKCI–PAR3 complex influences alveolar regeneration in emphysema-type COPD. URL: https://doi.org/10.1186/s13287-025-04189-6. Published February 2025. (wang2025thepar6bprkcipar3complex pages 5-8)

Summary
PARD6B (Par6β) is a human polarity scaffold that assembles the PAR3–PAR6–aPKC complex at the apical–lateral border, integrates CDC42 signaling to activate aPKC, and drives tight junction assembly and apical identity. Recent human embryoid and developmental studies reaffirm Par6’s apical role and CDC42 dependence. In disease, PARD6B is recurrently amplified/overexpressed in subsets of breast cancer with complex expression–outcome relationships and mislocalization in invasive disease, and it forms a pro-regenerative complex with PAR3 and PRKCI in alveolar epithelial cells with relevance to COPD. These functions underscore Par6β as a non-enzymatic organizer of epithelial architecture and signaling interfaces with implications for cancer biology and epithelial regeneration. (cunliffe2012par6bisrequired pages 1-2, wang2021identificationandcharacterization pages 33-37, nolan2008thepolarityprotein pages 6-7, catterall2021characterizationofapicalbasal pages 52-59, wang2025thepar6bprkcipar3complex pages 5-8)

References

1. (cunliffe2012par6bisrequired pages 1-2): HE Cunliffe, Y Jiang, and KM Fornace. Par6b is required for tight junction formation and activated pkcζ localization in breast cancer. Unknown journal, 2012.

2. (wang2021identificationandcharacterization pages 33-37): LT Wang. Identification and characterization of novel determinants of epithelial apical-basal polarity and lumen formation. Unknown journal, 2021.

3. (cunliffe2012par6bisrequireda pages 11-12): HE Cunliffe, Y Jiang, and KM Fornace. Par6b is required for tight junction formation and activated pkcζ localization in breast cancer. Unknown journal, 2012.

4. (nolan2008thepolarityprotein pages 6-7): Marissa E. Nolan, Victoria Aranda, Sangjun Lee, Balasubramanian Lakshmi, Srinjan Basu, D. Craig Allred, and Senthil K. Muthuswamy. The polarity protein par6 induces cell proliferation and is overexpressed in breast cancer. Cancer research, 68 20:8201-9, Oct 2008. URL: https://doi.org/10.1158/0008-5472.can-07-6567, doi:10.1158/0008-5472.can-07-6567. This article has 181 citations and is from a highest quality peer-reviewed journal.

5. (cunliffe2012par6bisrequireda pages 13-14): HE Cunliffe, Y Jiang, and KM Fornace. Par6b is required for tight junction formation and activated pkcζ localization in breast cancer. Unknown journal, 2012.

6. (catterall2021characterizationofapicalbasal pages 52-59): R Catterall. Characterization of apical-basal polarity as a tumor suppressive mechanism. Unknown journal, 2021.

7. (wang2025thepar6bprkcipar3complex pages 5-8): Di Wang, Hongbo Liu, Shuang Bai, Xuejian Zheng, and Li Zhao. The par6b-prkci-par3 complex influences alveolar regeneration in patients with the emphysema subtype of chronic obstructive pulmonary disease. Stem Cell Research & Therapy, Feb 2025. URL: https://doi.org/10.1186/s13287-025-04189-6, doi:10.1186/s13287-025-04189-6. This article has 1 citations and is from a peer-reviewed journal.

Citations

1. catterall2021characterizationofapicalbasal pages 52-59
2. wang2021identificationandcharacterization pages 33-37
3. nolan2008thepolarityprotein pages 6-7
4. https://doi.org/10.1158/0008-5472.can-07-6567
5. https://doi.org/10.1038/s41586-023-06368-y
6. https://doi.org/10.1186/s13287-025-04189-6
7. https://doi.org/10.1038/s41586-023-06368-y;
8. https://doi.org/10.3389/fendo.2023.1150017;
9. https://doi.org/10.3389/fncel.2024.1474010;
10. https://doi.org/10.1002/path.6056;
11. https://doi.org/10.1186/s13287-025-04189-6;
12. https://doi.org/10.1038/s41586-023-06368-y.
13. https://doi.org/10.3389/fendo.2023.1150017.
14. https://doi.org/10.3389/fncel.2024.1474010.
15. https://doi.org/10.1002/path.6056.
16. https://doi.org/10.1158/0008-5472.can-07-6567.
17. https://doi.org/10.1186/s13287-025-04189-6.
18. https://doi.org/10.1158/0008-5472.can-07-6567,
19. https://doi.org/10.1186/s13287-025-04189-6,

PARD6B: Partitioning Defective 6 Homolog Beta in Human (Par-6β)

Gene and Protein Overview

PARD6B (Par-6 beta) is a human gene encoding the polarity protein Par-6 homolog beta (also known as PAR6B). It belongs to the Par6 family of evolutionarily conserved cell-polarity regulators originally identified in C. elegans (the “partitioning defective” genes) (pmc.ncbi.nlm.nih.gov) (www.sciencedirect.com). Humans have three Par6 isoforms – Par6α (PARD6A), Par6β (PARD6B), and Par6γ (PARD6G) – which share common domain architecture and functions in polarity control (www.sciencedirect.com). Par6 proteins are adapter/scaffold molecules that form multi-protein complexes essential for asymmetric cell division and the establishment of cell polarity in many contexts (www.genecards.org) (www.genecards.org). Notably, Par6β is a cytoplasmic protein that translocates to specific cortical sites in cells to execute its function in coordination with other Par proteins (www.genecards.org).

Conservation and Importance: The Par6 family is highly conserved across species. The C. elegans par-6 gene is required for embryonic asymmetry, and homologs in flies and mammals perform analogous roles in organizing cell polarity (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). The critical role of PARD6B in development is underscored by mouse studies showing that Par6B is essential for forming the first polarized epithelium (trophectoderm) in the early embryo – loss of Pard6b disrupts blastocyst trophectoderm differentiation (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Thus, PARD6B encodes a fundamental polarity regulator whose absence can lead to severe developmental defects, reflecting its indispensable role in cell organization.

Structure and Domain Features

PARD6B’s protein product Par-6β is defined by several conserved domains that mediate its interactions (Figure 1). It contains an N-terminal PB1 (Phox/Bem1) domain – also referred to as an OPR domain – which enables heterodimerization with other PB1-domain proteins (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Notably, the PB1 of Par6β binds directly to the PB1 domain of atypical Protein Kinase C (aPKC), forming a Par6–aPKC complex (pmc.ncbi.nlm.nih.gov). Par6β also has a PDZ (PSD95/Discs-large/ZO-1) domain, a common protein–protein interaction module that in Par6 binds specific partner proteins at cell junctions (www.sciencedirect.com) (pmc.ncbi.nlm.nih.gov). Uniquely, Par6 proteins possess a semi-CRIB (Cdc42/Rac Interactive Binding) motif adjacent to the PDZ domain, which allows Par6β to bind the active (GTP-bound) forms of small Rho-family GTPases like Cdc42 and Rac1 (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). An IQ motif (a calmodulin-binding sequence) is present as well, suggesting additional regulatory interactions (for example, binding myosin light chain) (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). These domains collectively define Par6β’s role as a modular scaffold: the PB1 domain tethers aPKC, the PDZ domain connects to polarity proteins (such as Par3 or Crumbs), and the CRIB-like region docks Cdc42/Rac1, integrating signaling inputs (www.sciencedirect.com) (pmc.ncbi.nlm.nih.gov). The “Par6 homology” motif encompasses this arrangement (PB1–PDZ–CRIB) characteristic of all Par6 family members (www.genecards.org).

Key Interactions: Through its PDZ domain, Par6β directly interacts with PARD3 (Par3), another PDZ-domain polarity protein, forming the Par6–Par3 complex (www.genecards.org) (pmc.ncbi.nlm.nih.gov). Par6’s PDZ can also bind the C-terminal PDZ-binding motifs of transmembrane polarity proteins like CRB3 (Crumbs3) (pmc.ncbi.nlm.nih.gov) and the N-terminal region of LGL (lethal giant larvae tumor suppressor) (pmc.ncbi.nlm.nih.gov). These interactions localize Par6/aPKC to specific membrane sites. The CRIB-like region binds GTP-loaded Cdc42 or Rac1, which allosterically increases Par6’s affinity for partners like Par3 (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). In essence, active Cdc42 “recruits” Par6β to the cell cortex and enhances Par6’s binding to Par3 and other PDZ targets, aiding assembly of the polarity complex (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). The PB1 domain binding to aPKC not only sequesters the kinase at the correct location but also can relieve aPKC’s autoinhibition, contributing to aPKC activation (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Indeed, the binding of GTP-Cdc42 to Par6 is known to activate aPKC as part of the polarity signaling cascade (pmc.ncbi.nlm.nih.gov). Par6β itself is regulated by phosphorylation: for example, Par6 proteins can be phosphorylated by kinases like Aurora A or TGF-β receptor, which modulates their interactions (discussed below) (pmc.ncbi.nlm.nih.gov) (www.sciencedirect.com). Together, the domain structure of Par6β enables it to act as a central scaffold node linking small GTPases to aPKC and other polarity proteins (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). This scaffold function is crucial for the downstream events that establish cell polarity.

Role in Cell Polarity and Asymmetric Division

Par6β is a core component of the polarity complex that establishes apical–basal polarity in epithelial cells and other cell types. It functions in partnership with Par3 and aPKC (often called the Par3–Par6–aPKC complex, or Par complex) (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). This complex localizes to the apical side of polarized cells, especially at the tight junctions that demarcate apical and basolateral membranes (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). In cultured human epithelial cells, PARD6B is required for proper tight junction assembly: knockdown of PARD6B impairs the formation of epithelial tight junctions and disrupts apical–basal polarity (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). For example, silencing PARD6B in MCF7 breast epithelial cells causes loss of the tight junction network and mislocalization of aPKCζ from the membrane (pmc.ncbi.nlm.nih.gov). This indicates that Par6β is essential to recruit/activate aPKC at cell–cell contacts, which in turn signals the maturation of tight junctions (pmc.ncbi.nlm.nih.gov). Consistently, cells lacking Par6β or aPKC phenocopy the effects of losing Cdc42 – they fail to orient their polarity correctly (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). In a 3D morphogenesis model (Caco-2 cell cysts), depletion of Par6B was shown to mimic Cdc42 loss, leading to misoriented mitotic spindles, mispositioned apical surfaces, and aberrant multi-lumen cysts (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Par6β localizes to the apical surface of developing cysts and recruits aPKC to that site, helping define a single lumen; conversely, aPKC stabilizes Par6β (protecting it from degradation) (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). This interdependence ensures that the Par6–aPKC module is positioned at the nascent apical cortex to direct polarized cell division (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov).

In broader terms, Par6β and its partners govern the orientation of cell division and the segregation of cell-fate determinants during asymmetric cell division. In polarized neuroepithelial stem cells, for instance, Par complexes remain apically localized in the dividing cell, thereby biasing the distribution of fate determinants and influencing whether the division is symmetric or asymmetric (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Localization of Par6 (along with Par3 and aPKC) at the apical cortex of a dividing progenitor can ensure one daughter cell inherits the apical complex (maintaining a progenitor character) while the other does not, contributing to differentiation (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Notably, regulatory mechanisms link cell-cycle machinery to Par6 activity during division: in Drosophila, the mitotic kinase Aurora-A phosphorylates Par6, leading to activation of aPKC, phosphorylation of Lgl, and the polarized localization of cell fate determinant Numb to one daughter cell (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Similar principles apply in mammals – Par6β–aPKC phosphorylates targets like Lgl to release their inhibition on Par3 and to exclude certain proteins from the apical domain (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Through such actions, Par6β helps define distinct cortical domains in daughter cells. In summary, PARD6B plays a central role in establishing cell polarity axes, from guiding tight junction formation and apical domain identity in epithelia (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov) to coordinating mitotic spindle orientation and asymmetric outcome of divisions in development (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). These functions are tightly linked to its ability to integrate signals from cell–cell contacts and Rho GTPases and translate them into spatially organized aPKC activity.

Mechanistic insight – Par6β, Par3, and junction assembly: Par6β’s association with Par3 is thought to regulate the timing of tight junction assembly. Par3 can bind directly to junctional adhesion molecules like JAM-A (F11R) at nascent cell contacts; interestingly, when Par6 (PARD6B) binds Par3, it can prevent Par3’s interaction with JAM-A, thereby transiently preventing tight junction assembly (www.genecards.org). This suggests a regulatory mechanism where the Par6–Par3 complex must dissociate or rearrange to allow Par3 to engage JAM-A and finalize the tight junction. In early polarization, Par6–Par3–aPKC complexes accumulate at contacts, but Par6β-bound Par3 may hold off tight junction sealing until other polarity cues are aligned (www.genecards.org). Once conditions are appropriate, Par3 is released (possibly after aPKC phosphorylates Par3), freeing JAM-A and other components to form a mature tight junction. Thus, Par6β helps orchestrate junction assembly in a temporally controlled manner** by modulating Par3’s availability to junctional sites (www.genecards.org). This nuance exemplifies how Par6β not only initiates polarity signaling but also fine-tunes the formation of structural polarity features (like junctions) through its protein–protein interactions.

Integration into Signaling Pathways

Beyond its architectural role, Par6β participates in multiple signaling pathways that link cell polarity to changes in cell behavior. One well-studied pathway is TGF-β (transforming growth factor beta) signaling during epithelial–mesenchymal transition (EMT). In response to TGF-β, Par6 (likely including Par6β) becomes phosphorylated by the Type I TGF-β receptor at a conserved Ser/Thr site (pmc.ncbi.nlm.nih.gov) (www.sciencedirect.com). This phosphorylation enables Par6 to recruit an ubiquitin ligase, Smurf1, to the complex (pmc.ncbi.nlm.nih.gov). Smurf1, via Par6, then targets the small GTPase RhoA for ubiquitin-mediated degradation, leading to a loss of RhoA activity (www.sciencedirect.com). Since RhoA drives actin stress fiber formation and junctional tension, its downregulation causes dissolution of tight junctions and loss of polarity – early steps in EMT. In fact, a seminal study showed that TGF-β-induced phosphorylation of Par6 triggers RhoA degradation and breakup of epithelial junctions, promoting cell migration and invasiveness (www.sciencedirect.com). Thus, Par6β serves as a key node where extracellular TGF-β signals hijack the polarity machinery to induce phenotypic transformation. This mechanism connects polarity loss to cancer progression: by driving RhoA inactivation and junction disassembly, Par6 phosphorylation facilitates EMT and metastasis (www.sciencedirect.com).

Par6β also cross-talks with other major pathways that coordinate cell polarity and proliferation. For example, the Par6–aPKC complex can interface with the PI3K/Akt pathway and the MAPK/ERK pathway (www.sciencedirect.com). In certain contexts, Par6 proteins have been reported to interact with components of these signaling cascades, thereby influencing cell survival and growth in parallel to polarity. A recent review highlights that Par6 engages multiple signaling axes – including Wnt signaling and the Hippo pathway – in cancer cells, collectively promoting the loss of polarity and malignant progression (www.sciencedirect.com). One instance of cross-talk: Par6 (with Par3) can form a complex with phospholipase C-β (PLCβ) via their PDZ domains, stimulating PLCβ activity and downstream second messengers (DAG and IP3) that can affect cell dynamics (pmc.ncbi.nlm.nih.gov). Additionally, Par6–aPKC can inhibit RhoA signaling through alternative mechanisms: in neurons, Par6–aPKC activates p190 RhoGAP, thereby inactivating RhoA to promote dendritic spine development (pmc.ncbi.nlm.nih.gov). These interactions illustrate that Par6β is not an isolated polarity factor but an integrative hub connecting polarity with signaling networks. Through phosphorylation events and binding partnerships, Par6β influences pathways that govern cytoskeletal dynamics, cell cycle, and cell migration.

It is important to note that the Par6–aPKC complex’s activity is tightly regulated. Upstream signals (like Cdc42 activation or PIP₃ accumulation at the membrane) recruit and activate the complex (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov), while other inputs (like Aurora-A kinase during mitosis or Rho-kinase via Par3 phosphorylation) modulate it to achieve specific outcomes (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Furthermore, feedback loops exist: Par complex activity can feed back to activate or inhibit small GTPases and other signaling effectors (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). For instance, Par3–Par6–aPKC can activate Rac1 by recruiting guanine-nucleotide exchange factors, creating a positive feedback that reinforces polarized signaling (pmc.ncbi.nlm.nih.gov). Overall, PARD6B is a central player in a network of signaling pathways that ensure polarity cues are coordinated with cell growth and motility signals. Its ability to link extracellular signals (TGF-β, Wnt) and intracellular signaling (Rho GTPases, kinases) to the polarity apparatus is a cornerstone of how cells translate polarity changes into broader biological responses.

Subcellular Localization and Dynamics

Par6β is predominantly found at the cell cortex in polarized cells, reflecting its role at the interface of cell–cell contacts. While the protein can diffuse in the cytoplasm, it becomes enriched at specific sites upon receiving polarity cues. During epithelial polarization, Par6β concentrates at the apical membrane and tight junction region – the boundary between apical and lateral surfaces (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). For example, in 3D cysts of Caco-2 cells, Par6B is observed localizing to the developing apical surface, precisely where the lumen will form (pmc.ncbi.nlm.nih.gov). This apical recruitment depends on Par6β binding to active Cdc42 at the cortex and to Par3 and aPKC that are also targeted to nascent junctions (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). If Par6β is depleted, aPKC fails to localize apically and tight junction scaffolding is lost, underscoring that Par6β is required to anchor aPKC at the membrane (pmc.ncbi.nlm.nih.gov). Par6β can also localize to the leading edge or other polarized structures in migrating cells, in line with regions of active Cdc42. In neurons, Par6 (including Par6β isoform) localizes to the nascent axon tip, helping establish axon identity versus dendrites (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov).

Intracellularly, Par6β’s localization is dynamic: it cycles between the cytosol and cortical sites. Protein–protein interactions largely dictate Par6β positioning. When Par6β binds aPKC, the complex often associates with membranes (since aPKC has partial lipid-binding capacity and partners like Par3 can attach to membranes via lipid-binding domains) (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Additionally, transmembrane proteins like Crumbs3 that bind Par6 can recruit the Par6β–aPKC complex directly to the plasma membrane (pmc.ncbi.nlm.nih.gov). On the other hand, if aPKC is inhibited or Par6β is unbound, Par6β may remain in the cytoplasm. Par6β has also been detected at the centrosome in some cell types, potentially linked to its role in spindle orientation (since the Par complex can influence centrosome positioning) (pmc.ncbi.nlm.nih.gov). However, its primary functional locale is the cell cortex at polarity sites: apical junctions in epithelia, the apical endfoot of neural progenitors, the “front” of migrating cells, or the cytokinetic cleavage plane in dividing polarized cells (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). This spatially restricted localization allows Par6β to serve as a platform where specific enzymes (like aPKC) and small GTPases converge, ensuring that downstream phosphorylation events occur in the right place to define cellular asymmetry.

Clinical Significance and Recent Research Developments

Given its fundamental role in cell polarity, PARD6B has drawn attention in disease contexts, especially cancer. Loss of polarity is a hallmark of carcinoma progression, and polarity proteins like Par6β are often dysregulated in tumors (www.sciencedirect.com). Notably, PARD6B is located on chromosome 20, a region frequently amplified in cancers such as breast and colorectal carcinomas (pmc.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov). A 2012 study reported that PARD6B is amplified and overexpressed in a subset of breast cancers (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). In an analysis of 11 breast cancer cell lines, 5 lines harbored a PARD6B gene amplification (at 20q13.13), with copy-number increases up to 7–27 copies per cell (pmc.ncbi.nlm.nih.gov). This genomic amplification correlated with elevated Par6B mRNA and protein levels in those cells (pmc.ncbi.nlm.nih.gov). Functional experiments in the same study showed that Par6B overexpression was associated with robust tight junction structures in cultured monolayers, whereas Par6B silencing led to junctional defects, as mentioned earlier (pmc.ncbi.nlm.nih.gov). Immunohistochemistry on breast tumor samples further found Par6β to be expressed specifically in epithelial tumor cells (absent in stroma), although staining intensity varied and only subtle quantitative differences were noted between tumors (pmc.ncbi.nlm.nih.gov). These findings suggest that some cancers select for increased Par6B, potentially to exploit its polarity-regulating functions. Interestingly, maintaining some aspects of cell polarity via Par6B might confer advantages to tumor cells in certain microenvironments (for example, organizing invasive fronts or sustaining growth in epithelioid clusters).

Recent research has uncovered a direct pro-tumor role for PARD6B in colorectal cancer (CRC). A 2025 study (Park et al., published in Cancer Science) showed that PARD6B is frequently upregulated in CRC and promotes tumor growth by modulating oncogenic signaling (pmc.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov). The PARD6B gene lies in a region of chromosome 20 often gained in CRC, and its mRNA expression was found to be significantly higher in colorectal tumors than in normal tissue, correlating with DNA copy-number gain (pubmed.ncbi.nlm.nih.gov). High PARD6B expression was associated with advanced disease and poorer patient prognosis (pubmed.ncbi.nlm.nih.gov). Functionally, elevated Par6B drives proliferation of CRC cells: in vitro and in vivo experiments demonstrated that PARD6B positively regulates cancer cell proliferation and cell-cycle progression (pubmed.ncbi.nlm.nih.gov). Mechanistically, Par6B overexpression in CRC was shown to upregulate the oncogene MYC by suppressing a tumor-suppressor microRNA (miR-34c) (pmc.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov). miR-34c normally would repress MYC; thus, Par6B creates a permissive environment for MYC overexpression, fueling cell growth. This PARD6B–miR-34c–MYC axis represents a novel connection between a polarity protein and the core proliferation machinery (pmc.ncbi.nlm.nih.gov). The same study noted that PARD6B mRNA overexpression is a poor prognostic factor in multiple cancer types, and it proposed PARD6B as a promising prognostic biomarker and potential therapeutic target in CRC (pubmed.ncbi.nlm.nih.gov). Targeting Par6B or its downstream interactions (for instance, disrupting Par6–aPKC or Par6–Cdc42 binding) could be explored as a strategy to impair tumor cell polarity signals that are supporting growth and survival. While no Par6-specific inhibitors exist yet, the identification of Par6B’s impact on pathways like MYC suggests that patients with PARD6B-high tumors might benefit from therapies targeting those downstream oncogenic pathways (pmc.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov).

More broadly, emerging data indicate that different Par6 isoforms may have context-specific roles in cancer. According to a 2025 comprehensive review, Par6 family proteins show tumor-type-specific expression patterns and clinical implications (www.sciencedirect.com). For example, PARD6A (Par6α) was recently implicated in ovarian cancer cell invasion via EMT pathways, whereas PARD6B (Par6β) appears more prominently in breast and colorectal cancers (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Despite these differences, a common theme is that overexpression or dysregulation of Par6 proteins can contribute to loss of cell polarity, enhanced migration, and uncontrolled proliferation in tumors (www.sciencedirect.com). Par6-mediated polarity signaling intersects with oncogenic pathways (TGF-β, PI3K/Akt, Wnt, etc.), meaning that aberrant Par6 activity can tip the balance toward tumor progression (www.sciencedirect.com). Clinically, this makes components of the Par complex interesting as biomarkers: high Par6 expression might indicate an aggressive tumor phenotype or specific vulnerabilities. For instance, the CRC study suggests monitoring PARD6B levels could inform prognosis, and combining Par6B status with other molecular data might refine patient stratification (pubmed.ncbi.nlm.nih.gov). There is also interest in whether Par6β could be therapeutically targeted. While directly drugging a scaffold protein is challenging, disrupting its critical interactions (like Par6–aPKC) or downstream effects (like the Par6→RhoA or Par6→MYC pathways) could yield new anti-cancer strategies. Additional research is ongoing to map all interaction partners of Par6β and how they contribute to oncogenic processes.

Expert Perspectives and Future Directions

Cell polarity regulators like Par6β are now recognized as more than just “housekeeping” proteins – experts consider them key orchestrators of complex cellular behaviors. A recent authoritative review (Cell Signalling, 2025) emphasizes that Par6 “plays a crucial role in controlling cell polarity,” with its PDZ, CRIB, and PB1 domains enabling diverse signaling interactions that establish polarity (www.sciencedirect.com). Researchers Vargas et al. (2025) highlight that Par6’s functional versatility allows it to coordinate structural polarity with signaling pathways involved in cell proliferation and survival (www.sciencedirect.com). They note that Par6 (including Par6β) lies at a crossroads of pathways – citing its involvement in TGF-β-driven EMT, and its ability to engage PI3K/Akt, MAPK/ERK, and Wnt signaling – thereby integrating polarity loss with malignant transformation (www.sciencedirect.com). Such expert analyses suggest that PARD6B is not only central to normal epithelial biology but also to pathological processes like cancer metastasis. There is a growing consensus that studying polarity proteins can yield insights into disease mechanisms: for example, how a tumor cell loses organized structure and gains invasive capacity.

Going forward, key questions remain about PARD6B’s regulation and potential as a drug target. Post-translational modifications (phosphorylation by various kinases, ubiquitination, etc.) of Par6β are an active research area, as these modifications dictate Par6β’s activity and localization. Understanding these regulatory layers could open opportunities to modulate Par6β function pharmacologically. Another area of interest is the isoform-specific functions of Par6 proteins: why do mammals have three Par6 genes and do they have non-redundant roles? Some studies hint that Par6β might be specialized for certain tissues or signals – for instance, it may preferentially partner with aPKCζ versus aPKCλ, or have distinct affinities for Cdc42 vs Rac1 compared to Par6α (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Deciphering these nuances could inform tissue-specific interventions (e.g. targeting Par6β in cancers where it is the dominant isoform).

In summary, PARD6B (Par-6β) is a pivotal cell polarity regulator with a well-defined role in organizing the Par polarity complex at the cell cortex. Its scaffold function links GTPases like Cdc42 to the activation and localization of aPKC, driving the assembly of polarity structures such as tight junctions (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). By controlling cell polarity and asymmetric division, Par6β ensures normal tissue architecture and development. Simultaneously, it serves as a conduit for signaling pathways (TGF-β, PI3K, etc.) that can repurpose the polarity machinery to influence cell migration and proliferation (www.sciencedirect.com). Recent research underscores Par6β’s clinical relevance, implicating it in cancer progression where its overexpression can promote tumor growth and metastasis (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov). As our understanding of PARD6B deepens, it stands out as both a fundamental piece of the cell polarity puzzle and a potential bridge between loss of polarity and disease, making it a compelling subject for continued investigation in cell biology and oncology.

Figures: Diagrammatic representation of Par6B domain structure and the Par6–Par3–aPKC complex localization in a polarized epithelial cell (with Par6B at the apical junction, interacting with Cdc42 and aPKC). (Refer to sources such as Joberty 2000 (pmc.ncbi.nlm.nih.gov) and Lin 2000 (pmc.ncbi.nlm.nih.gov) for original discovery of Par6 interactions.)

Citations

1. AnnotationURLCitation(end_index=504, start_index=373, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=JR%2C%20Kemphues%20KJ%20%281996%29%20par,Google')
2. AnnotationURLCitation(end_index=678, start_index=505, title='Polarity protein Par6: Unraveling its mechanisms in tumor development and research advances - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/pii/S0898656825005960#:~:text=Par6%20plays%20a%20crucial%20role,The%20PDZ%2C%20CRIB%20%28Cdc42%2FRac')
3. AnnotationURLCitation(end_index=1013, start_index=840, title='Polarity protein Par6: Unraveling its mechanisms in tumor development and research advances - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/pii/S0898656825005960#:~:text=Par6%20plays%20a%20crucial%20role,The%20PDZ%2C%20CRIB%20%28Cdc42%2FRac')
4. AnnotationURLCitation(end_index=1360, start_index=1193, title='PARD6B Gene - GeneCards | PAR6B Protein | PAR6B Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=PARD6B#:~:text=Adapter%20protein%20involved%20in%20asymmetrical,PARD3%20complex%20links%20GTP')
5. AnnotationURLCitation(end_index=1490, start_index=1361, title='PARD6B Gene - GeneCards | PAR6B Protein | PAR6B Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=PARD6B#:~:text=This%20gene%20is%20a%20member,See%20more')
6. AnnotationURLCitation(end_index=1783, start_index=1654, title='PARD6B Gene - GeneCards | PAR6B Protein | PAR6B Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=PARD6B#:~:text=This%20gene%20is%20a%20member,See%20more')
7. AnnotationURLCitation(end_index=2154, start_index=2023, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=JR%2C%20Kemphues%20KJ%20%281996%29%20par,Google')
8. AnnotationURLCitation(end_index=2334, start_index=2155, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=Proper%20neurodevelopment%20is%20regulated%20by,chromosome%20location%20of%20these%20homologous')
9. AnnotationURLCitation(end_index=2733, start_index=2593, title='Cell Polarity Regulator PARD6B Is Essential for Trophectoderm Formation in the Preimplantation Mouse Embryo - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2924801/#:~:text=Cell%20Polarity%20Regulator%20PARD6B%20Is,%28n%20%3D%203')
10. AnnotationURLCitation(end_index=2869, start_index=2734, title='Cell Polarity Regulator PARD6B Is Essential for Trophectoderm Formation in the Preimplantation Mouse Embryo - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2924801/#:~:text=PMCID%3A%20PMC2924801%C2%A0%C2%A0PMID%3A%2020505164')
11. AnnotationURLCitation(end_index=3462, start_index=3343, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=match%20at%20L296%20calmodulin,2005')
12. AnnotationURLCitation(end_index=3561, start_index=3463, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=PB1%20%20,2005')
13. AnnotationURLCitation(end_index=3785, start_index=3687, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=PB1%20%20,2005')
14. AnnotationURLCitation(end_index=4125, start_index=3952, title='Polarity protein Par6: Unraveling its mechanisms in tumor development and research advances - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/pii/S0898656825005960#:~:text=Par6%20plays%20a%20crucial%20role,The%20PDZ%2C%20CRIB%20%28Cdc42%2FRac')
15. AnnotationURLCitation(end_index=4224, start_index=4126, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=PDZ%20%20,2003')
16. AnnotationURLCitation(end_index=4571, start_index=4452, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=match%20at%20L296%20calmodulin,2005')
17. AnnotationURLCitation(end_index=4731, start_index=4572, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=match%20at%20L400%20The%20binding,conformational%20changes%20in%20Par6%20to')
18. AnnotationURLCitation(end_index=5008, start_index=4889, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=match%20at%20L296%20calmodulin,2005')
19. AnnotationURLCitation(end_index=5127, start_index=5009, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=Par6%27s%20N%20terminus%20%20,2009')
20. AnnotationURLCitation(end_index=5556, start_index=5383, title='Polarity protein Par6: Unraveling its mechanisms in tumor development and research advances - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/pii/S0898656825005960#:~:text=Par6%20plays%20a%20crucial%20role,The%20PDZ%2C%20CRIB%20%28Cdc42%2FRac')
21. AnnotationURLCitation(end_index=5716, start_index=5557, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=match%20at%20L400%20The%20binding,conformational%20changes%20in%20Par6%20to')
22. AnnotationURLCitation(end_index=5959, start_index=5830, title='PARD6B Gene - GeneCards | PAR6B Protein | PAR6B Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=PARD6B#:~:text=This%20gene%20is%20a%20member,See%20more')
23. AnnotationURLCitation(end_index=6290, start_index=6123, title='PARD6B Gene - GeneCards | PAR6B Protein | PAR6B Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=PARD6B#:~:text=Adapter%20protein%20involved%20in%20asymmetrical,PARD3%20complex%20links%20GTP')
24. AnnotationURLCitation(end_index=6390, start_index=6291, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=PDZ1%20%20,2005')
25. AnnotationURLCitation(end_index=6632, start_index=6510, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=at%20the%20apical%20side,Yamanaka%20et')
26. AnnotationURLCitation(end_index=6835, start_index=6709, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=match%20at%20L517%20at%20the,Yamanaka%20et')
27. AnnotationURLCitation(end_index=7189, start_index=7030, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=match%20at%20L400%20The%20binding,conformational%20changes%20in%20Par6%20to')
28. AnnotationURLCitation(end_index=7340, start_index=7190, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=The%20binding%20of%20GTP,conformational%20changes%20in%20Par6%20to')
29. AnnotationURLCitation(end_index=7665, start_index=7506, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=match%20at%20L400%20The%20binding,conformational%20changes%20in%20Par6%20to')
30. AnnotationURLCitation(end_index=7788, start_index=7666, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=at%20the%20apical%20side,Yamanaka%20et')
31. AnnotationURLCitation(end_index=8054, start_index=7956, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=PB1%20%20,2005')
32. AnnotationURLCitation(end_index=8237, start_index=8055, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=their%20pleckstrin%20homology%20domains%20to,complexes%2C%20making%20Par%20complexes%20integration')
33. AnnotationURLCitation(end_index=8534, start_index=8352, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=their%20pleckstrin%20homology%20domains%20to,complexes%2C%20making%20Par%20complexes%20integration')
34. AnnotationURLCitation(end_index=8889, start_index=8732, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=asymmetric%20cell%20division,specificity%20of%20aPKC%20and%20consequently')
35. AnnotationURLCitation(end_index=9077, start_index=8890, title='Polarity protein Par6: Unraveling its mechanisms in tumor development and research advances - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/pii/S0898656825005960#:~:text=tumors%20and%20their%20divergent%20clinical,the%20Par6%20complex%20by%20phosphatases')
36. AnnotationURLCitation(end_index=9385, start_index=9226, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=match%20at%20L400%20The%20binding,conformational%20changes%20in%20Par6%20to')
37. AnnotationURLCitation(end_index=9568, start_index=9386, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=their%20pleckstrin%20homology%20domains%20to,complexes%2C%20making%20Par%20complexes%20integration')
38. AnnotationURLCitation(end_index=10121, start_index=9952, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=match%20at%20L107%20Par3%2C%20Par6%2C,to%20these%20protein%20complexes%20collectively')
39. AnnotationURLCitation(end_index=10221, start_index=10122, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=PDZ1%20%20,2005')
40. AnnotationURLCitation(end_index=10518, start_index=10371, title='PAR6B is required for tight junction formation and activated PKCζ localization in breast cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3433109/#:~:text=Dysregulation%20of%20mechanisms%20that%20govern,Expression%20of')
41. AnnotationURLCitation(end_index=10691, start_index=10519, title='Par6B and Atypical PKC Regulate Mitotic Spindle Orientation during Epithelial Morphogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3069449/#:~:text=partner%2C%20atypical%20protein%20kinase%20C,induces%20robust%20apoptotic%20cell%20death')
42. AnnotationURLCitation(end_index=11044, start_index=10897, title='PAR6B is required for tight junction formation and activated PKCζ localization in breast cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3433109/#:~:text=Dysregulation%20of%20mechanisms%20that%20govern,Expression%20of')
43. AnnotationURLCitation(end_index=11221, start_index=11045, title='PAR6B is required for tight junction formation and activated PKCζ localization in breast cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3433109/#:~:text=related%20isoforms%20PARD6A%20and%20PARD6G,quantitative%20differences%20in%20staining%20were')
44. AnnotationURLCitation(end_index=11550, start_index=11374, title='PAR6B is required for tight junction formation and activated PKCζ localization in breast cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3433109/#:~:text=related%20isoforms%20PARD6A%20and%20PARD6G,quantitative%20differences%20in%20staining%20were')
45. AnnotationURLCitation(end_index=11871, start_index=11695, title='PAR6B is required for tight junction formation and activated PKCζ localization in breast cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3433109/#:~:text=related%20isoforms%20PARD6A%20and%20PARD6G,quantitative%20differences%20in%20staining%20were')
46. AnnotationURLCitation(end_index=12178, start_index=12004, title='Par6B and Atypical PKC Regulate Mitotic Spindle Orientation during Epithelial Morphogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3069449/#:~:text=reported%20that%20Cdc42%20controls%20mitotic,and%20aPKC%20function%20interdependently%20in')
47. AnnotationURLCitation(end_index=12351, start_index=12179, title='Par6B and Atypical PKC Regulate Mitotic Spindle Orientation during Epithelial Morphogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3069449/#:~:text=partner%2C%20atypical%20protein%20kinase%20C,induces%20robust%20apoptotic%20cell%20death')
48. AnnotationURLCitation(end_index=12733, start_index=12559, title='Par6B and Atypical PKC Regulate Mitotic Spindle Orientation during Epithelial Morphogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3069449/#:~:text=reported%20that%20Cdc42%20controls%20mitotic,and%20aPKC%20function%20interdependently%20in')
49. AnnotationURLCitation(end_index=12906, start_index=12734, title='Par6B and Atypical PKC Regulate Mitotic Spindle Orientation during Epithelial Morphogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3069449/#:~:text=partner%2C%20atypical%20protein%20kinase%20C,induces%20robust%20apoptotic%20cell%20death')
50. AnnotationURLCitation(end_index=13279, start_index=13100, title='Par6B and Atypical PKC Regulate Mitotic Spindle Orientation during Epithelial Morphogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3069449/#:~:text=Cdc42%2C%20inducing%20misorientation%20of%20the,different%20thresholds%20of%20aPKC%20expression')
51. AnnotationURLCitation(end_index=13432, start_index=13280, title='Par6B and Atypical PKC Regulate Mitotic Spindle Orientation during Epithelial Morphogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3069449/#:~:text=multiple%20lumens,spindle%20orientation%20in%20polarized%20epithelia')
52. AnnotationURLCitation(end_index=13738, start_index=13566, title='Par6B and Atypical PKC Regulate Mitotic Spindle Orientation during Epithelial Morphogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3069449/#:~:text=partner%2C%20atypical%20protein%20kinase%20C,induces%20robust%20apoptotic%20cell%20death')
53. AnnotationURLCitation(end_index=13891, start_index=13739, title='Par6B and Atypical PKC Regulate Mitotic Spindle Orientation during Epithelial Morphogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3069449/#:~:text=multiple%20lumens,spindle%20orientation%20in%20polarized%20epithelia')
54. AnnotationURLCitation(end_index=14471, start_index=14295, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=divisions%2C%20whereas%20asymmetric%20divisions%20produce,a%20basal%20daughter%20cell%20that')
55. AnnotationURLCitation(end_index=14642, start_index=14472, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=spatiotemporal%20manners%20%28Liu%20et%20al,supported%20by%20studies%20of%20asymmetric')
56. AnnotationURLCitation(end_index=15057, start_index=14890, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=match%20at%20L710%20asymmetrically%20depends,all%20regulated%20by%20Par%20complexes')
57. AnnotationURLCitation(end_index=15228, start_index=15058, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=spatiotemporal%20manners%20%28Liu%20et%20al,supported%20by%20studies%20of%20asymmetric')
58. AnnotationURLCitation(end_index=15681, start_index=15524, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=asymmetric%20cell%20division,specificity%20of%20aPKC%20and%20consequently')
59. AnnotationURLCitation(end_index=15848, start_index=15682, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=phosphorylates%20and%20activates%20DmPar,promote%20its%20basal%20localization%20in')
60. AnnotationURLCitation(end_index=16183, start_index=16026, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=asymmetric%20cell%20division,specificity%20of%20aPKC%20and%20consequently')
61. AnnotationURLCitation(end_index=16310, start_index=16184, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=match%20at%20L517%20at%20the,Yamanaka%20et')
62. AnnotationURLCitation(end_index=16707, start_index=16560, title='PAR6B is required for tight junction formation and activated PKCζ localization in breast cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3433109/#:~:text=Dysregulation%20of%20mechanisms%20that%20govern,Expression%20of')
63. AnnotationURLCitation(end_index=16884, start_index=16708, title='PAR6B is required for tight junction formation and activated PKCζ localization in breast cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3433109/#:~:text=related%20isoforms%20PARD6A%20and%20PARD6G,quantitative%20differences%20in%20staining%20were')
64. AnnotationURLCitation(end_index=17156, start_index=16984, title='Par6B and Atypical PKC Regulate Mitotic Spindle Orientation during Epithelial Morphogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3069449/#:~:text=partner%2C%20atypical%20protein%20kinase%20C,induces%20robust%20apoptotic%20cell%20death')
65. AnnotationURLCitation(end_index=17336, start_index=17157, title='Par6B and Atypical PKC Regulate Mitotic Spindle Orientation during Epithelial Morphogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3069449/#:~:text=Cdc42%2C%20inducing%20misorientation%20of%20the,different%20thresholds%20of%20aPKC%20expression')
66. AnnotationURLCitation(end_index=18083, start_index=17916, title='PARD6B Gene - GeneCards | PAR6B Protein | PAR6B Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=PARD6B#:~:text=Adapter%20protein%20involved%20in%20asymmetrical,PARD3%20complex%20links%20GTP')
67. AnnotationURLCitation(end_index=18576, start_index=18409, title='PARD6B Gene - GeneCards | PAR6B Protein | PAR6B Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=PARD6B#:~:text=Adapter%20protein%20involved%20in%20asymmetrical,PARD3%20complex%20links%20GTP')
68. AnnotationURLCitation(end_index=19046, start_index=18879, title='PARD6B Gene - GeneCards | PAR6B Protein | PAR6B Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=PARD6B#:~:text=Adapter%20protein%20involved%20in%20asymmetrical,PARD3%20complex%20links%20GTP')
69. AnnotationURLCitation(end_index=19785, start_index=19687, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=PB1%20%20,2005')
70. AnnotationURLCitation(end_index=19973, start_index=19786, title='Polarity protein Par6: Unraveling its mechanisms in tumor development and research advances - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/pii/S0898656825005960#:~:text=tumors%20and%20their%20divergent%20clinical,the%20Par6%20complex%20by%20phosphatases')
71. AnnotationURLCitation(end_index=20235, start_index=20068, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=match%20at%20L1981%20Rho%20GTPases,Molecular%20characterization%20of%20CDC42%2C%20a')
72. AnnotationURLCitation(end_index=20552, start_index=20365, title='Polarity protein Par6: Unraveling its mechanisms in tumor development and research advances - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/pii/S0898656825005960#:~:text=tumors%20and%20their%20divergent%20clinical,the%20Par6%20complex%20by%20phosphatases')
73. AnnotationURLCitation(end_index=21092, start_index=20905, title='Polarity protein Par6: Unraveling its mechanisms in tumor development and research advances - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/pii/S0898656825005960#:~:text=tumors%20and%20their%20divergent%20clinical,the%20Par6%20complex%20by%20phosphatases')
74. AnnotationURLCitation(end_index=21591, start_index=21404, title='Polarity protein Par6: Unraveling its mechanisms in tumor development and research advances - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/pii/S0898656825005960#:~:text=tumors%20and%20their%20divergent%20clinical,the%20Par6%20complex%20by%20phosphatases')
75. AnnotationURLCitation(end_index=21986, start_index=21805, title='Polarity protein Par6: Unraveling its mechanisms in tumor development and research advances - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/pii/S0898656825005960#:~:text=interactions%20of%20PAR6%20in%20tumor,the%20Par6%20complex%20by%20phosphatases')
76. AnnotationURLCitation(end_index=22560, start_index=22379, title='Polarity protein Par6: Unraveling its mechanisms in tumor development and research advances - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/pii/S0898656825005960#:~:text=interactions%20of%20PAR6%20in%20tumor,the%20Par6%20complex%20by%20phosphatases')
77. AnnotationURLCitation(end_index=22934, start_index=22786, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=match%20at%20L605%20G,signaling%20plays%20important%20roles%20in')
78. AnnotationURLCitation(end_index=23264, start_index=23133, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=that%20the%20loss%20of%20Cdc42%2C,In%20addition')
79. AnnotationURLCitation(end_index=23915, start_index=23765, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=The%20binding%20of%20GTP,conformational%20changes%20in%20Par6%20to')
80. AnnotationURLCitation(end_index=24098, start_index=23916, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=their%20pleckstrin%20homology%20domains%20to,complexes%2C%20making%20Par%20complexes%20integration')
81. AnnotationURLCitation(end_index=24402, start_index=24245, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=asymmetric%20cell%20division,specificity%20of%20aPKC%20and%20consequently')
82. AnnotationURLCitation(end_index=24568, start_index=24403, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=neurons%20by%20activating%20p190%20RhoGAP,and%20downstream%20of%20Par%20complexes')
83. AnnotationURLCitation(end_index=24849, start_index=24707, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=activate%20aPKC%20%28Yamanaka%20et%20al,Pard3%20can%20also')
84. AnnotationURLCitation(end_index=25015, start_index=24850, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=neurons%20by%20activating%20p190%20RhoGAP,and%20downstream%20of%20Par%20complexes')
85. AnnotationURLCitation(end_index=25322, start_index=25180, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=activate%20aPKC%20%28Yamanaka%20et%20al,Pard3%20can%20also')
86. AnnotationURLCitation(end_index=26330, start_index=26151, title='Par6B and Atypical PKC Regulate Mitotic Spindle Orientation during Epithelial Morphogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3069449/#:~:text=Cdc42%2C%20inducing%20misorientation%20of%20the,different%20thresholds%20of%20aPKC%20expression')
87. AnnotationURLCitation(end_index=26507, start_index=26331, title='PAR6B is required for tight junction formation and activated PKCζ localization in breast cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3433109/#:~:text=related%20isoforms%20PARD6A%20and%20PARD6G,quantitative%20differences%20in%20staining%20were')
88. AnnotationURLCitation(end_index=26829, start_index=26650, title='Par6B and Atypical PKC Regulate Mitotic Spindle Orientation during Epithelial Morphogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3069449/#:~:text=Cdc42%2C%20inducing%20misorientation%20of%20the,different%20thresholds%20of%20aPKC%20expression')
89. AnnotationURLCitation(end_index=27134, start_index=26975, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=match%20at%20L400%20The%20binding,conformational%20changes%20in%20Par6%20to')
90. AnnotationURLCitation(end_index=27314, start_index=27135, title='Par6B and Atypical PKC Regulate Mitotic Spindle Orientation during Epithelial Morphogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3069449/#:~:text=Cdc42%2C%20inducing%20misorientation%20of%20the,different%20thresholds%20of%20aPKC%20expression')
91. AnnotationURLCitation(end_index=27657, start_index=27481, title='PAR6B is required for tight junction formation and activated PKCζ localization in breast cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3433109/#:~:text=related%20isoforms%20PARD6A%20and%20PARD6G,quantitative%20differences%20in%20staining%20were')
92. AnnotationURLCitation(end_index=28050, start_index=27918, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=match%20at%20L405%20Cdc42%20distributes,lymphoma')
93. AnnotationURLCitation(end_index=28214, start_index=28051, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=aPKC%CE%B6%20can%20be%20activated%20to,mediated%20aPKC%CE%B6%20activation%20for')
94. AnnotationURLCitation(end_index=28734, start_index=28574, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=1988%2C%201995%3B%20Steinberg%2C%202008%29,by%20contrast%2C%20aPKC%20require')
95. AnnotationURLCitation(end_index=28914, start_index=28735, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=and%20activation%20of%20Par%20complexes,from%20nonspecific%20electrostatic%20interactions%20and')
96. AnnotationURLCitation(end_index=29146, start_index=29048, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=PDZ%20%20,2004')
97. AnnotationURLCitation(end_index=29600, start_index=29426, title='Par6B and Atypical PKC Regulate Mitotic Spindle Orientation during Epithelial Morphogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3069449/#:~:text=reported%20that%20Cdc42%20controls%20mitotic,and%20aPKC%20function%20interdependently%20in')
98. AnnotationURLCitation(end_index=30026, start_index=29850, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=divisions%2C%20whereas%20asymmetric%20divisions%20produce,a%20basal%20daughter%20cell%20that')
99. AnnotationURLCitation(end_index=30199, start_index=30027, title='Par6B and Atypical PKC Regulate Mitotic Spindle Orientation during Epithelial Morphogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3069449/#:~:text=partner%2C%20atypical%20protein%20kinase%20C,induces%20robust%20apoptotic%20cell%20death')
100. AnnotationURLCitation(end_index=30929, start_index=30742, title='Polarity protein Par6: Unraveling its mechanisms in tumor development and research advances - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/pii/S0898656825005960#:~:text=tumors%20and%20their%20divergent%20clinical,the%20Par6%20complex%20by%20phosphatases')
101. AnnotationURLCitation(end_index=31180, start_index=31062, title='PAR6B is required for tight junction formation and activated PKCζ localization in breast cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3433109/#:~:text=apico,aPKC%29%2C%20but%20did%20not')
102. AnnotationURLCitation(end_index=31342, start_index=31181, title='Polarity Gene PARD6B Promotes Tumor Growth of Colorectal Cancer via Increasing MYC Expression - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/40533910/#:~:text=which%20is%20frequently%20amplified%20in,unlike%20other%20polarity%20gene%20groups')
103. AnnotationURLCitation(end_index=31590, start_index=31443, title='PAR6B is required for tight junction formation and activated PKCζ localization in breast cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3433109/#:~:text=Dysregulation%20of%20mechanisms%20that%20govern,Expression%20of')
104. AnnotationURLCitation(end_index=31709, start_index=31591, title='PAR6B is required for tight junction formation and activated PKCζ localization in breast cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3433109/#:~:text=apico,aPKC%29%2C%20but%20did%20not')
105. AnnotationURLCitation(end_index=32030, start_index=31874, title='PAR6B is required for tight junction formation and activated PKCζ localization in breast cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3433109/#:~:text=In%20this%20study%20we%20report,TJ%20network%20formation%20in%20cultured')
106. AnnotationURLCitation(end_index=32247, start_index=32129, title='PAR6B is required for tight junction formation and activated PKCζ localization in breast cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3433109/#:~:text=apico,aPKC%29%2C%20but%20did%20not')
107. AnnotationURLCitation(end_index=32652, start_index=32476, title='PAR6B is required for tight junction formation and activated PKCζ localization in breast cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3433109/#:~:text=related%20isoforms%20PARD6A%20and%20PARD6G,quantitative%20differences%20in%20staining%20were')
108. AnnotationURLCitation(end_index=33056, start_index=32896, title='PAR6B is required for tight junction formation and activated PKCζ localization in breast cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3433109/#:~:text=cell%20monolayers.%20SiRNA,quantitative%20differences%20in%20staining%20were')
109. AnnotationURLCitation(end_index=33837, start_index=33682, title='Polarity Gene PARD6B Promotes Tumor Growth of Colorectal Cancer via Increasing MYC Expression - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12400055/#:~:text=Skip%20to%20main%20content%20Cancer,a%20polarity%20gene%2C%20functions')
110. AnnotationURLCitation(end_index=33999, start_index=33838, title='Polarity Gene PARD6B Promotes Tumor Growth of Colorectal Cancer via Increasing MYC Expression - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/40533910/#:~:text=highly%20expressed%20PARD6B%20can%20promote,and%20therapeutic%20target%20for%20CRC')
111. AnnotationURLCitation(end_index=34376, start_index=34215, title='Polarity Gene PARD6B Promotes Tumor Growth of Colorectal Cancer via Increasing MYC Expression - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/40533910/#:~:text=which%20is%20frequently%20amplified%20in,unlike%20other%20polarity%20gene%20groups')
112. AnnotationURLCitation(end_index=34618, start_index=34467, title='Polarity Gene PARD6B Promotes Tumor Growth of Colorectal Cancer via Increasing MYC Expression - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/40533910/#:~:text=mRNA%20expression%20is%20a%20poor,and%20therapeutic%20target%20for%20CRC')
113. AnnotationURLCitation(end_index=34955, start_index=34820, title='Polarity Gene PARD6B Promotes Tumor Growth of Colorectal Cancer via Increasing MYC Expression - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/40533910/#:~:text=prognostic%20factor,silico%20and%20in%20vitro%20analyses')
114. AnnotationURLCitation(end_index=35262, start_index=35100, title='Polarity Gene PARD6B Promotes Tumor Growth of Colorectal Cancer via Increasing MYC Expression - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12400055/#:~:text=Partitioning%20Defective%206B%20,promising%20therapeutic%20target%20for%20CRC')
115. AnnotationURLCitation(end_index=35424, start_index=35263, title='Polarity Gene PARD6B Promotes Tumor Growth of Colorectal Cancer via Increasing MYC Expression - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/40533910/#:~:text=highly%20expressed%20PARD6B%20can%20promote,and%20therapeutic%20target%20for%20CRC')
116. AnnotationURLCitation(end_index=35837, start_index=35675, title='Polarity Gene PARD6B Promotes Tumor Growth of Colorectal Cancer via Increasing MYC Expression - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12400055/#:~:text=Partitioning%20Defective%206B%20,promising%20therapeutic%20target%20for%20CRC')
117. AnnotationURLCitation(end_index=36200, start_index=36049, title='Polarity Gene PARD6B Promotes Tumor Growth of Colorectal Cancer via Increasing MYC Expression - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/40533910/#:~:text=mRNA%20expression%20is%20a%20poor,and%20therapeutic%20target%20for%20CRC')
118. AnnotationURLCitation(end_index=36806, start_index=36644, title='Polarity Gene PARD6B Promotes Tumor Growth of Colorectal Cancer via Increasing MYC Expression - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12400055/#:~:text=Partitioning%20Defective%206B%20,promising%20therapeutic%20target%20for%20CRC')
119. AnnotationURLCitation(end_index=36958, start_index=36807, title='Polarity Gene PARD6B Promotes Tumor Growth of Colorectal Cancer via Increasing MYC Expression - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/40533910/#:~:text=mRNA%20expression%20is%20a%20poor,and%20therapeutic%20target%20for%20CRC')
120. AnnotationURLCitation(end_index=37386, start_index=37212, title='Polarity protein Par6: Unraveling its mechanisms in tumor development and research advances - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/pii/S0898656825005960#:~:text=Par6%20isoforms%20show%20tumor,patterns%20and%20clinical%20significance')
121. AnnotationURLCitation(end_index=37718, start_index=37571, title='PAR6B is required for tight junction formation and activated PKCζ localization in breast cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3433109/#:~:text=Dysregulation%20of%20mechanisms%20that%20govern,Expression%20of')
122. AnnotationURLCitation(end_index=37874, start_index=37719, title='Polarity Gene PARD6B Promotes Tumor Growth of Colorectal Cancer via Increasing MYC Expression - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12400055/#:~:text=Skip%20to%20main%20content%20Cancer,a%20polarity%20gene%2C%20functions')
123. AnnotationURLCitation(end_index=38268, start_index=38081, title='Polarity protein Par6: Unraveling its mechanisms in tumor development and research advances - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/pii/S0898656825005960#:~:text=tumors%20and%20their%20divergent%20clinical,the%20Par6%20complex%20by%20phosphatases')
124. AnnotationURLCitation(end_index=38636, start_index=38449, title='Polarity protein Par6: Unraveling its mechanisms in tumor development and research advances - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/pii/S0898656825005960#:~:text=tumors%20and%20their%20divergent%20clinical,the%20Par6%20complex%20by%20phosphatases')
125. AnnotationURLCitation(end_index=39139, start_index=38988, title='Polarity Gene PARD6B Promotes Tumor Growth of Colorectal Cancer via Increasing MYC Expression - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/40533910/#:~:text=mRNA%20expression%20is%20a%20poor,and%20therapeutic%20target%20for%20CRC')
126. AnnotationURLCitation(end_index=40184, start_index=40011, title='Polarity protein Par6: Unraveling its mechanisms in tumor development and research advances - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/pii/S0898656825005960#:~:text=Par6%20plays%20a%20crucial%20role,The%20PDZ%2C%20CRIB%20%28Cdc42%2FRac')
127. AnnotationURLCitation(end_index=40569, start_index=40382, title='Polarity protein Par6: Unraveling its mechanisms in tumor development and research advances - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/pii/S0898656825005960#:~:text=tumors%20and%20their%20divergent%20clinical,the%20Par6%20complex%20by%20phosphatases')
128. AnnotationURLCitation(end_index=41005, start_index=40818, title='Polarity protein Par6: Unraveling its mechanisms in tumor development and research advances - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/pii/S0898656825005960#:~:text=tumors%20and%20their%20divergent%20clinical,the%20Par6%20complex%20by%20phosphatases')
129. AnnotationURLCitation(end_index=42249, start_index=42127, title='PAR6B is required for tight junction formation and activated PKCζ localization in breast cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3433109/#:~:text=,the%20requirement%20of%20a%20complete')
130. AnnotationURLCitation(end_index=42343, start_index=42250, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=CRIB,2000')
131. AnnotationURLCitation(end_index=42976, start_index=42800, title='PAR6B is required for tight junction formation and activated PKCζ localization in breast cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3433109/#:~:text=related%20isoforms%20PARD6A%20and%20PARD6G,quantitative%20differences%20in%20staining%20were')
132. AnnotationURLCitation(end_index=43129, start_index=42977, title='Par6B and Atypical PKC Regulate Mitotic Spindle Orientation during Epithelial Morphogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3069449/#:~:text=multiple%20lumens,spindle%20orientation%20in%20polarized%20epithelia')
133. AnnotationURLCitation(end_index=43600, start_index=43413, title='Polarity protein Par6: Unraveling its mechanisms in tumor development and research advances - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/pii/S0898656825005960#:~:text=tumors%20and%20their%20divergent%20clinical,the%20Par6%20complex%20by%20phosphatases')
134. AnnotationURLCitation(end_index=43921, start_index=43760, title='Polarity Gene PARD6B Promotes Tumor Growth of Colorectal Cancer via Increasing MYC Expression - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/40533910/#:~:text=highly%20expressed%20PARD6B%20can%20promote,and%20therapeutic%20target%20for%20CRC')
135. AnnotationURLCitation(end_index=44073, start_index=43922, title='Polarity Gene PARD6B Promotes Tumor Growth of Colorectal Cancer via Increasing MYC Expression - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/40533910/#:~:text=mRNA%20expression%20is%20a%20poor,and%20therapeutic%20target%20for%20CRC')
136. AnnotationURLCitation(end_index=44691, start_index=44593, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=PB1%20%20,2005')
137. AnnotationURLCitation(end_index=44804, start_index=44705, title='The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9188383/#:~:text=PDZ1%20%20,2005')